filename,md5
BCBS_NE_V77.pdf,f47478decb72464e11f0b693e96aa6f5
BCBS_FEP_204128 Genetic Testing for Fanconi Anemia.pdf,256b78fe459f554d84bc7079abe8ff28
BCBS_Illinois_RX501.135_2025-01-01.pdf,129a0e32dac19d731678bf3d959beccc
BCBS_Kansas_genetic-testing-diagnosis-inherited-peripheral-neuropathies.pdf,43a8c343768172734ebdf55dd28e3d5a
Blue Cross Idaho_02.02.528_03-27-25.pdf,08bb378f758dd91b6d84081edf6cdbec
HealthPartner_metabolic and mitochondrial disorders.pdf,fe2b0518843f5b9d898474b1ed1ff495
Asuris_Northwest_Health_Genetic Testing for Hereditary Breast and Ovarian Cancer and Li-Fraumeni Syndrome.pdf,7371ffce1d26e89c136d9d1eda84bf2a
Vermont_Colon cancer Lynch syndrome clinical criteria 083024.pdf,81895609ed8e54370585098370933057
BCBS_Illinois_PSY301.014_2024-12-15.pdf,478f3d4e244d770cad5aef45443a0040
Asuris_Northwest_Health_Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening.pdf,3ce48c7438517410c6bdbaaced9672ca
Asuris_Northwest_Health_Genetic and Molecular Diagnostic Testing.pdf,9855fe1444007d1984c4fe651bb2b3d7
Humana_Genetic Testing for Diagnosis of Inherited Conditions - MEDICAID - SOUTH CAROLINA.pdf,78bab57874a0890e94f0d687b66ed606
BCBS_FEP_20443 Genetic Testing for Cardiac.pdf,c2edc3d2407d3bfc9175f1743f9f6ac8
Vermont_Gene Expression Profiling for Managing Breast Cancer_083024.pdf,9498a2ea3e0f5e1555110697c5819972
Sentara_Genetic Testing - Preconceptional-Prenatal-Preimplantation Commerical - Medical 34D.pdf,c7834c02e29c9fc61064c6196e46ba06
BCBS_MI.pdf,a0b9ea288914a7e28d88b7fcb4987290
North Dakota Medicaid_genetic testing.pdf,acebe290a6095fdb4c945b3dba0c04db
United Healthcare_preimplantation-genetic-testing.pdf,ba5c767229f4e4120c1cfd3e787e5f5b
BCBS_NE_V35.pdf,1f3221b5a487c275a23561b20dbbb256
Humana_Genetic Testing for Cystic Fibrosis - Commercial.pdf,4cd2db18163f51fba2144e536e898ea4
Asuris_Northwest_Health_Neurofibromatosis.pdf,7e8f00d8f3f2c515033a93fb6247ab7b
V2.2023 Concert Genetics Skeletal Dysplasia & Rare Bone Disorders.pdf,75dbb151e4ba50a3d0d91cd5f37a5a6d
JohnsHopkinsHealthcare.pdf,bb62f2c30ff759fbc7d333a6480933be
Cigna_MOL.TS_.371.A_Noonan_Spectrum_Disorder_Genetic_eff01.01.2025_pub09.11.2024_0.pdf,97b1f3a9da791c1694b99e558fe71905
Amerihealth_Caritas_NH_ccp1002-cell-free-DNA-prenatal-screening.pdf,cedbc5f7559634ac98f9d6c4ffc629b8
Driscoll_Cystic-Fibrosis.pdf,381bcf91cf4fb67fb3021e27bd1f02b7
Humana_Genetic Testing for Hematologic Malignancies and Suspected Myeloid Disorders - Commercial.pdf,64cdd4a53557d3f4bc2cf9e5709783d2
BCBS_NE_V56.pdf,48ccf1209b30685b214ed532caff289e
CapitalBC_Duchenne and Becker Muscular Dystrophy.pdf,3d9a703694a5938451f7d344eab2c65a
"Aetna_Breast and Ovarian Cancer Susceptibility Gene Testing, Prophylactic Mastectomy, and Prophylactic Oophorectomy - Medical Clinical Policy Bulletins.pdf",853350c3473bcef32091186fbb7318fd
BCBS_MI4.pdf,c72be9213abe0f146ae2ac4c73f3a05f
Asuris_Northwest_Health_Conceptio_Pregnancy_Loss.pdf,26343888c3eb299923ca4e7280b67ad2
HealthParners_general approach to genetic and molecular testing.pdf,6cb1565e776481900815e41752382f41
United Healthcare_pharmacogenetic-testing.pdf,b6576d5f30f7e9519cb7acf546710c8d
Caresource_Ohio_medicaid.pdf,244f8332842127e5420d19e2f758a01d
BCBS_HW_GTM Prenatal Screening (Genetic) AHS-M2179 2025-0301.pdf,dfdeb9ec1d3aacf73592f65f78ed2d8d
HealthParners_gastroenterologic.pdf,3eed90691ea553c8c8d210ea4a3c8a83
Humana_Genetic Testing for Hereditary Colorectal and Uterine Cancer - Commercial.pdf,4aa636d20c3609d0f5af716bdd3599c4
FallonHealth_Prenatal Screening.pdf,779e3fe5d73f2c17ee162e9984e8e278
Cigna_MOL.TS_.169.A_Familial_Hypercholesterolemia_eff01.01.2025_09.10.2024_1.pdf,3199911828daacf88a11cb5f75193b01
Cigna_MOL.TS_.271.A_PancraGen_eff01.01.2025_pub09.12.2024_0.pdf,1995dcc7eda0418b42c5a036d4a05ddf
BCBS_NE_X165.pdf,4a15a6312059f490b74625b483d89dc9
HealthParners_prenatal diagnosis and pregnancy loss.pdf,38d39da5e5e7e6f06f4420f10ea66a4f
BCBS_NE_V19.pdf,e2b755293d98c674b3ef75eb16ee337c
BCBS_HW_GTM Molecular Diagnostics for Breast Cancer Prognosis (Formerly Molecular Expression Testing for Breast Cancer)  AHS-M2020 2025-0201.pdf,e2add222dd756619a4cf283d2a2b3820
Blue Cross Idaho_02.04.116_08-29-24.pdf,9dde2abc52a1bd09e7e1b5791279072f
Humana_Genetic and Coagulation Testing for Noncancer Blood Disorders - Commercial.pdf,bed3919a7262bdc0f8b69cff5c08eb9a
BCBS_HW_GTM Testing for Alpha-1 Antitrypsin Deficiency AHS-M2068 2025-0201.pdf,68135ed2c6c57567bbf0361431da22f1
Cigna_MOL.CU_.114.A_Genetic_Testing_to_Diagnose_Non_Cancer_Conditions_eff01.01.2025_09.12.2024_0.pdf,d2bf7936ea4c2dd8a9d0a6cc732df8e2
Humana_Genetic Testing for Diagnosis of Inherited Conditions - MEDICAID - VIRGINIA.pdf,a639b060d18635f037f2701f8d68e993
BCBS_Illinois_RX501.136_2025-04-01.pdf,8b2667ef87823fb874a6f939cd3f6f45
V2.2023 Concert Genetics- Dermatologic Conditions.pdf,0d1830d6b6872bba8a215ef2f9a981cb
Wellmark BCBS_Lab Mgmt_V2.0.2025_eff07.01.2025_pub02.24.2025_upd05.05.2025.pdf,e9a0a5a8998c9f4141c26805775d7b4d
tricare_manual.pdf,94c104b726ff453b6e554c6529992336
BCBS_HW_GTM Genetic Testing and Genetic Expression Profiling in Patients with Cutaneous Melanoma AHS–M2029 2023-0601_v2.pdf,635cd8a7124bc929b9bf4e30497eafe9
Asuris_Northwest_Health_Genetic Testing for Lactase Insufficiency.pdf,bea0d56ec99e3c91f5802700f3631e08
United Healthcare_molecular-oncology-testing-for-cancer.pdf,e9b2f948b39d675ac181772318a45966
Oklahoma Medicaid_Genetic Molecular Pathology Guideline 3-7-2023.pdf,942e7630f50161a88b1f92931aecc57c
"BCBS_HW_GTM Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers AHS–M2003 2025-0201.pdf",bf65d26c76ebdcda94be9953f40abc13
Humana_Genetic Testing for Muscular Dystrophy and Spinal Muscular Atrophy - Commercial.pdf,fa560179746dfa6ab8e70e5995cd0c69
Ameriheath_Caritas_PA_ccp1121-genetic-testing-prostate-cancer-prognosis.pdf,65ee0c7c287c183389a2bf1f03b087c2
CapitalBC_medical-policy-genetic-testing-for-mitochondrial-disorders.pdf,6daa6f235a45f7cd90454201d824b6ab
BCBS_FEP_20433 Genetic and Protein Biomarkers.pdf,4659468418040c626c04c700ecf7be33
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Skeletal-Dysplasia-Rare-Bone-Disorders.pdf,b92507bee7daedaaba5bdf8c04124c7f
Sentara_Genetic Testing - Pharmacogenetic Testing Medicare - Medical 34E.pdf,4e1358e4aa3041ef9856713e6bc48024
BCBS_NE_X96.pdf,ee0b3b3010991c66786deab8ddd3f286
CapitalBC_medical-policy-genetic-testing-for-hereditary-hearing-loss.pdf,0f7fd1b80ad910ef2ac2a28f0461a2b2
BCBS_NE_V70.pdf,a13c596cf2a0eb2f9d0e04902029697e
CountryCare2.pdf,6311a978ce176aefc5da5b421c4a2719
Asuris_Northwest_Health_Microarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk Stratification.pdf,113b83c8edd6429aa7a90464b3f6592f
Humana_Genetic and Biomarker Testing for Alzheimer Disease - Commercial.pdf,9b1eb97c78ad78fc1757a60fc344cdc7
BCBS_HW_GTM Molecular Testing for Pulmonary Specimens  AHS–M2160 2025-0201.pdf,c5b9ba1ff69cb5a71e9a13724e766747
Humana_Genetic Testing for Marfan Syndrome and Related Conditions - Commercial.pdf,849621240ced656e51f5dbd471f7b961
Ameriheath_Caritas_PA_ccp1153-genetic-testing-for-cystic-fibrosis.pdf,0db8092de7156f29415ef1f4e6eeeb22
Asuris_Northwest_Health_Genetic Testing for Statin-Induced Myopathy.pdf,1bf3891ae99c71e1412db829796b5fa1
Sentara_Genetic Testing - Preconceptional-Prenatal-Preimplantation Medicare - Medical 34D.pdf,60754777b3a4bfe3791d003ddd311cbd
BCBS_NE_V21.pdf,88142b22d8ab57656c29601ee65853b1
BCBS_MI2.pdf,1f03a3db46397164cd93e6184eedb27c
CapitalBC_Alpha Thalassemia.pdf,12af3a54168614f2749efd31f9cfc49a
Cigna_MOL.TS_.170.A_Familial_Malignant_Melanoma_eff01.01.2025_09.10.2024_1.pdf,59e60d36c014c2c0cd7117a9a0116c20
BCBS_NE_V68.pdf,8f9ae97d4ecf91cf74f5618a05b8cd73
Aetna_Genetic Testing - Medical Clinical Policy Bulletins.pdf,719687f5d7b033f155f6d338f3db16f6
Humana_Genetic Testing - Medicare Advantage.pdf,35c49391bc3131a391de980a2b2c23cc
caresource_passe_genetictesting.pdf,483568933ae5b3b46e0b9c8fa2e2b632
AnthemBCBS_MED.00142 Gene Therapy for Cerebral Adrenoleukodystrophy.pdf,5c1a79c3c46fc8dfd07dba41536e142f
CapitalBC_medical-policy-genetic-testing-for-helicobacter-pylori-treatment.pdf,4e352c14fad6f726f6edc30c00188721
Vermont_Myeloproliferative Disease Genetic Testing Criteria 12.17.24.pdf,4f5e530eb5252b1f5433e591b115e6ab
Health Partners Plan_mn008c-genetic-testing.pdf,9f395f922e69c5a0a60cab793ab1fab8
Cigna_MOL.TS_.125.A_Amyotrophic_Lateral_Sclerosis_eff01.01.2025_pub09.10.2024_1.pdf,1437f21e1dc36eb9c33ce925a22fbb89
Cigna_MOL.TS_.311.A_SCA_Spinocerebellar_Ataxia_Genetic_Testing_eff01.01.2025_pub09.11.2024_0.pdf,330de0c32bf475b9e97df35c2fee24ca
BCBS_Kansas_genetic-testing-cardiac-ion-channelopathies.pdf,0be7f7ff061f5b3cdb56c710b7909fc1
Carelon_Amerigroup_BCBSAlabama_Somatic_Tumor.pdf,d94b3a6b67f42637bf7a1714d5cba584
AnthemBCBS_MED.00135 Gene Therapy for Hemophilia.pdf,a9b4841abccbd0186c070b795f1cd290
BCBS_FEP_20493 Genetic Cancer Susceptibility.pdf,6a528ee78d784175658bc9ec36329f51
CapitalBC_Alpha1 Antitrypsin deficiency.pdf,97660ce0f445661896910c14f8614c0c
BCBS_FEP_20487 Genetic Testing for HHL.pdf,08d000330740492481a8b76e7a90ed29
Asuris_Northwest_Health_Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis Syndromes.pdf,fcca39bd7fe17bb16079bf4e289faa62
Blue Cross Idaho_02.04.129_02-27-25.pdf,2786b29df5e8af450845bdcd8dd81141
Blue Cross Idaho_02.04.099_02-27-25.pdf,fb137d6269c9f59828b58dbf8101aa59
CapitalBC_medical-policy-genetic-testing-for-idiopathic-dilated-cardiomyopathy.pdf,c71119e06410f381d1ff4b8df3c1c38f
Blue Cross Idaho_02.04.109_03-27-25.pdf,6e611745e459d4f4935f7f47be882b45
Oklahoma Medicaid_Genetic Molecular Pathology Guideline.pdf,166933c4fa6e92171f03c125fa828ddf
BCBS_MA_163 Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes.pdf,6ca26ee5b03e9588ed7f831bd31e1477
CapitalBC_Developmental delay.pdf,4e9dc924d0da4f069db6e9db082856b1
HealthParners_circulating tumor DNA.pdf,4d981619f8d0c37e66138cd4a14f3d06
Asuris_Northwest_Health_Genetic Testing for Methionine Metabolism Enzymes- including-MTHFR.pdf,de8e0a624218ca37438712b1052423e1
BCBS_MA_336 Biomarkers for Diagnosis & Cancer Risk Assessment of Prostate Cancer prn.pdf,9345a7c36f6ee7f16cca8495251bd39d
Dean_HealthPlan_Genetic-Testing-Epilepsy-Neuro-DX-9591.pdf,2ea87769de75537c0cf99a0a254606a2
Asuris_Northwest_Health_SNVs_risk_of_Nonfamilial_Breast_cancer.pdf,1db330b2c171065294727407543ecc50
BCBS_HW_GTM Genetic Testing for Li-Fraumeni Syndrome AHS-M2081 2023-0601_v2.pdf,c172a9ea3ae14065652282a5b75b4363
Sentara_Genetic Testing - Pharmacogenetic Testing Commercial - Medical 34E.pdf,8d9330ca849080f7de04aa057b6d48dc
CapitalBC_medical-policy-genetic-testing-for-FLT3-NPM1-and-CEBPA-variants-in-cytogenetically-normal-acute-myeloid-leukemia.pdf,c934fa420ffe14f633e0c63b48368919
BCBS_HW_GTM Lynch Syndrome AHS–M2004 2025-0201.pdf,66af163eec99299748997d1b254adf55
Ameriheath_Caritas_PA_ccp1037-genetic-testing-long-qt-syndrome.pdf,3ab5fc7190a4cbacf77cab53e9ee262b
BCBS_HW_GTM Genetic Testing For PTEN Hamartoma Tumor Syndrome AHS-M2087 2025-0201.pdf,63bc83fac899d8593a4cf42285427733
Vermont_Melanoma Gene Expression Profiling Criteria 04.18.25.pdf,83618f52c06da54836c92696662a7ca4
V2.2023 Concert Genetic Testing- Lung Disorders.pdf,bb4b8d5131acacae998b2ccbc6826797
HealthParners_skeletal dysplasia and rare bone disorders.pdf,af2590ccf3221893492b9643c23ca2d7
HealthParners_immune autoimmune and rheumatoid disorders.pdf,e62ce65d89dd47e7fba714eebc0485c8
Asuris_Northwest_Health_Connective Tissue.pdf,f67fbd31dcb472bb0bf90bdcfc062385
BCBS_HW_GTM Testing for Colorectal Cancer Management (Formerly KRAS NRAS BRAF Mutation Analysis in Colorectal Cancer) AHS-M2026 2025-0201.pdf,ae8eca2aa4fd1d53f64a5ffacfef5236
Asuris_Northwest_Health_Serologic Genetic and Molecular Screening for Colorectal Cancer.pdf,0cdd5f06832082b34065ed022297a586
Cigna_MOL.TS_.258.A_MODY_eff01.01.2025_pub09.12.2024_0.pdf,c40e957d42548fd6b983c593b4aec6ba
South Carolina Medicaid_Genetic testing.pdf,0770db389808bab40802aeef34b414fc
Humana_Genetic Testing - Commercial.pdf,e9e519d4d0f445272eb5d6dd1213f544
Driscoll_Non_Ivasive_Prenatal_Screening.pdf,eabd53fa23492f2c297251acbb945999
oxford_pharmacogenetic-testing-ohp.pdf,110c450fa72ea8310a16254b79a8581b
Vermont_Vibration controlled Fibroscan for web.pdf,e2d865042d01ac528f3ad0074a91c770
Blue Cross Idaho_04.02.005_08-29-24.pdf,ad6cdd23cd161972aadbe9d83bf88493
BCBS_NE_V73.pdf,aa0e1b322587cd0bb75a67aeaef8a391
Sentara_FF - Genetic and Molecular Testing Commercial Medical 34.pdf,171a434ea13f8027ee4291ae5a9fda55
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Prenatal-DX-Amniocentesis-CVS-PUBS-Pregnancy-Loss.pdf,5de97acae73621ddeaa8263594e5b443
HealthParners_prenatal and preconception carrier screening.pdf,32e6bb195e106183db31bab9b295e8ab
BCBS_FEP_20444 Germline Genetic Testing for.pdf,40e1df8aa16cd679b840d308d3901b73
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Kidney-Disorders.pdf,8cc3f6fa7eeac34c58dd37bf7fe32661
BCBS_Illinois_RX501.102_2025-02-01.pdf,79a5f399bf2c38ecb82a8e6c46cb8bd7
BCBS_HW_GTM Genetic Testing for Cystic Fibrosis AHS-M2017 2025-0201.pdf,4d0ab8e498632ea7e4206d23c6d4bf7b
BCBS_Illinois_RX501.086_2024-12-15.pdf,2d08d44c84c201143e6c85bf10db48b2
Blue Cross Idaho_02.04.117_10-31-24.pdf,46ba1a1feb643df09e4842d671a6f9bc
BCBS_AZ_luxturna-voretigene-neparvovec-rxyl.pdf,234609f27e3fab8053941992d033dfb2
Vermont_Prostate Cancer Genomic Assay for web_0.pdf,3b874a777f48ab082a7cbf8de3f30fb5
AnthemBCBS_MED.00129 Gene Therapy for Spinal Muscular Atrophy.pdf,5666290467d40ee0551b5937df97c196
BCBS_HW_GTM Genetic Cancer Susceptibility Using Next Generation Sequencing AHS-M2066 2025-0201.pdf,bbc012f40aa075420082425da41158dc
BCBS_HW_GTM Pharmacogenetic Testing AHS-M2021 2025-0201.pdf,8e5d5bfe315421abb68c070ddddfd97c
"BCBS_HW_GTM Genetic Testing for Duchenne, Becker, Facioscapulohumeral, and Limb-Girdle Muscular Dystrophies AHS-M2074 2023-0601_v2.pdf",275c1ef6a9b8f5160b4f0c398bfb1f01
RockyMountain_preimplantation-genetic-testing-rmhp.pdf,d67318b6ea29da146286b29fb19d5297
V2.2023 Concert Genetic Testing- Exome & Genome Sequencing for Dx of Genetic Disorders.pdf,ce0d60a053cbb9307005fc54b339d1b3
Humana_Genetic Testing for Hereditary Ataxias - Medicare Advantage.pdf,3f43067f62d0f5cb209781d88c9a7899
Oscar_CG012_Non-Covered_EIU_Services.pdf,25e4daef3da98d4886be430405badfe2
BCBS_Rhode_Island_2024 Genetic Testing Services - Effective 4.1.2025.pdf,59015033ee7110e7c6e506da977763c5
BCBS_FEP_20489 Genetic Testing for the.pdf,38c76092afaec912a922f2b5178c72eb
Carelon_Amerigroup_BCBSAlabama_WES_WGS.pdf,cfe05deaae6a4d57d28029197befaf10
Amerihealth Caritas_NC_1S-12.pdf,4398a799f9189884c3fea99eebbd662e
Asuris_Northwest_Health_Apolipoprotein E for Risk Assessment and Management of Cardiovascular Disease.pdf,1dc208b8c21828a102712a5b1d59e65a
Capital Health Plan_Gene_Expression.pdf,8b7ef55c291b7c601ec71b3ff8eddf17
Highmark_Wholecare.pdf,b2049eccb34e16b306671273bbe3ad03
"BCBS_HW_GTM General Genetic Testing, Somatic Disorders AHS–M2146 2023-0601_v2.pdf",4d30766e78e78c7e6a39ba7b3b5e9222
Capital Health Plan_Lynch Syndrome.pdf,2d5c4911e9b32021fce759129b8441f3
United Healthcare_cell-free-fetal-dna-testing.pdf,a5626c765e3950c31ab778b1087b6daa
BCBS_FEP_204101 Genetic Testing for Li Fraumeni.pdf,c50dd2f37f5fff8fde04566dfa5109c0
AetnaBettherHealth_Kentucky_Clinical Policy Updates Genetic Testing.pdf,7e1e8d82e00c1db8d96a1996206d9da6
CapitalBC_medical-policy-genetic-testing-for-lynch-syndrome-and-other-inherited-colon-cancer-syndromes.pdf,2a82215e210b6e788fa67085a2e5c101
CapitalBC_medical-policy-genetic-testing-for-facioscapulohumeral-muscular-dystrophy.pdf,77237e0ecd7c19f3eabc6292e92182a3
Humana_Genetic Testing for Methylene Tetrahydrofolate Reductase - Commercial.pdf,b7201cbdd39876b6b425170ddd46aa23
BCBS_HW_GTM Molecular Profiling for Cancers of Unknown Primary Origin AHS-M2065 2025-0201.pdf,016b9a629a670bf1e87991a11fd849fb
HealthParners_eye disorders.pdf,b56d7e533d860985c4945a705d56eb7f
BCBS_Illinois_RX501.129_2025-02-15.pdf,9c3bc01462d446e9584eed14f6098e5b
Asuris_Northwest_Health_Reproductive Carrier Screening for Genetic Diseases.pdf,a2d3903e5553c5e06a371a7226fb2ba9
Cigna_MOL.TS_.257.A_Epilepsy_Genetic_Testing_eff01.01.2025_09.12.2024_0.pdf,4294c14f5a75e85016751a11a928b18c
BCBS_HW_GTM Proteogenomic Testing of Individuals with Cancer AHS-M2168 2025-0201.pdf,1c057a868df9099c2684c5fb29ac6005
CT_Medicaid_GeneticTestingPolicy.pdf,90dfbef15651c026d10a3905134dd718
Asuris_Northwest_Health_Cutaneous Malignant Melanoma.pdf,920ac84b412f14e056f210ec908efa80
BCBS_NE_V64.pdf,da5e75c5d1870697ade97a346289cefd
BCBS_NE_X190.pdf,4b04b430cfe9404a15c0dadf5fee2142
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Lung-Disorders.pdf,0fe04717866ff7762270cf997ecf4b54
Asuris_Northwest_Health_Alpha Thalassemia.pdf,8942650da98ddd14e3ee66e271374be7
CountryCare_Genetic-Testing-PA.259.CC-ver-Apr-25.pdf,7a63acba15c4dc4765b81a9a1a91d038
Cigna_MOL.TS_.309.A_FRDA_Friedreichs_Ataxia_Genetic_Testing_eff01.01.2025_pub09.10.2024_1.pdf,f19bb745133ef61fb8f71068c1eadf28
United Healthcare_fda-companion-diagnostic-testing.pdf,ec18463ddbf0e61da8b7f9a09edbf7fb
BCBS_FEP_20408 Genetic Testing for Lynch.pdf,a4bac0fea3745ff3a0284c6fd4a4ec19
HealthParners_kidney disorders.pdf,ed98e9d51e9fdbcec8c39ddea0c25ea8
Harvard Pilgrim Health Plan_Tufts Health Plan_Noncovered_Investigational_Services-mng.pdf,937cc3e10c448959aafc1c7557ae04d8
CapitalBC_medical-policy-genetic-testing-for-familial-cutaneous-malignant-melanoma.pdf,1b0d7e5aaef3921da3b09f61806f49fd
Blue Cross Idaho_02.04.137_01-30-25.pdf,69985e3d2aa9706f6162d266a0bc7f32
Cigna_MOL.TS_.248.A_Breast_Cancer_Index_Coverage_eff01.01.2025_pub09.10.2024_1.pdf,e3d37fed9b814cd78e63ff70febce3b3
Dean_HealthPlan_Genetic-Testing-Skeletal-Dysplasia-9603.pdf,321ae3257253ccae740f1048a5692167
BCBS_HW_GTM Pre-Implantation Genetic Testing AHS-M2039  2025-0201.pdf,1629a86908d770425f4d6e3d0b27d0f6
Asuris_Northwest_Health_Myeloid_Neoplasms.pdf,d0ff2c075e9886f7274b2807ae0268c3
BCBS_Kansas_genetic-cancer-susceptibility-panels-using-next-generation-sequencing.pdf,6ad08dab5037487e0ed2e41c44af1b5a
BCBS_Kansas_genetic-testing-marfan-syndrome-thoracic-aortic-aneurysms-and-dissections-and.pdf,033a14e9d88351500c9c7582276517bc
Blue Cross Idaho_02.04.508_09-26-24.pdf,dd8e0f068e68dde62db6907048e9b1e6
Sentara_FF - Genetic and Molecular Testing  Medicaid Medical 34.pdf,826a8244b3bdce69dac662b27710c9f8
Cigna_MOL.TS_.227.A_TAAD_Panel_Testing_eff01.01.2025_pub09.10.2024_1.pdf,a2c57457574dde5538dd8329a861c583
Blue Cross Idaho_02.04.091_05-29-25.pdf,7e5fee777b7f3461a5daa728f3bdce22
CountryCare_Gene-Expression-Testing-for-Breast-Cancer-Policy-PA.018.CC-ver-Jul-24.pdf,6311a978ce176aefc5da5b421c4a2719
CapitalBC_medical-policy-2-363.pdf,b79718e0664ca6eef84e65c62f6e3c39
Humana_Genetic Testing for Cardiac Conditions - Commercial.pdf,aa9e820fe903d1c3ea2a0f9d16fdc7f9
BCBS_Illinois_RX501.172_2024-09-15.pdf,7ee1611fa2e6bbcbade86266b50aa3fe
BCBS_NE_X224.pdf,2316091f4b1d2cb3846ca332c469afb5
BCBS_FEP_20499 Genetic Testing for Hereditary.pdf,4fdfc9f6b254a54978ce9a5ae108507c
AnthemBCBS_LAB.00050 Metagenomic Sequencing for Infectious Disease in the Outpatient Setting.pdf,219be052807aca2d11535e5c2d4ca89d
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Epilepsy-Neurodegen-Neuromuscular-Disorders.pdf,b230668b2192d70dc6fe166c5e6c5748
Oxford_whole-exome-whole-genome-sequencing-ohp.pdf,d3a77c0013e66023cd4a88473f834408
West Virginia_Medicaid_Polcy529.1LaboratoryandPathologyServicesPublicCommentDraft.pdf,b167917c226660ffbf78c94e3aab2fa2
Oxford_genetic-testing-hereditary-cancer-ohp.pdf,efd770dc055d2d8f13b286f6bcbebc13
Sentara_Genetic Testing—Pre-Treatment or Post-Intervention Medicare - Medical 34B.pdf,895a2681fc0485505e46ba2c62cf5edf
V2.2023 Concert Genetic Testing- Eye Disorders.pdf,3600b2aa135d5d273bcb4de2232eee18
BCBS_FEP_204103 Genetic Testing for Macular.pdf,788f8916e7309f1a30382d1a462c8f93
Common Ground Healthcare Cooperative_marketplace-policy-medical-mm-1617-20241201.pdf,74dd4807682f9ddd52f5d400ebf603f8
BCBS_HW_GTM Genetic Testing for Rett Syndrome AHS-M2088 2023-0601_v2.pdf,78bf385f4bc389d1c1edfcb2317ea2eb
Asuris_Northwest_Health_Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer.pdf,d6b7df71b6365d8a953cbdd4a4367aeb
Ameriheath_Caritas_PA_ccp1252-genetic-testing-hereditary-cardiomyopathy.pdf,1b3f28e84c8664468805dbc1b6cee5f9
Cigna_MOL.CU_.110.A_Genetic_Testing_for_Carrier_Status_eff01.01.2025_09.12.2024_0.pdf,0e01cbfa9a4721f66408ce4174c30cd4
Cigna_MOL.TS_.197.A_Lynch_Syndrome_Genetic_Testing_eff01.01.2025_pub09.10.2024_1.pdf,9a3a6313cd9f25a9b340bfd02a6a5222
BCBS_FEP_20402 Germline Genetic Testing for.pdf,c5c2b854957d06467835e88a963d0c82
BCBS_HW_GTM Genetic Testing for Familial Alzheimer Disease AHS-M2038 2025-0201.pdf,bf969466bd548f90a6b459c0bf45d6bb
Dean_HealthPlan_Genetic-Testing-Somatic-Tumor-Markers-9486.pdf,b31c1ca489ebc655f486602f4b3ed4ab
Asuris_Northwest_Health_Invasive_Prenatal_Fetal_Diagnostic.pdf,5a718e3699dd39fe45021ef3c504f41a
HealthParners_oncology.pdf,2012ceb661720b8dccddfe6d8a3a55f0
CapitalBC_medical-policy-genetic-testing-for-neurofibromatosis.pdf,ce17a84561e951bb6bb6e436ab1767f1
BCBS_FEP_204107 Carrier Screening for Genetic.pdf,9caaacbd3ecd63a2275efa3467ceff16
BCBS_HW_GTM Genetic Testing for Inherited Cardiomyopathies and Channelopathies AHS-M2025 2023-0601_v2.pdf,5fff8197580adbf49020fc8fcf0f5600
Dean_HealthPlan_Onc-Algorithmic-Testing-9605.pdf,5e282e142371eb8330492d41da4a6a31
Sentara_Genetic Testing - Preconceptional-Prenatal-Preimplantation Medicaid - Medical 34D.pdf,c98319eb8b81e512029439ab56d3d809
BCBS_HW_GTM General Genetic Testing - Germline Disorders AHS-M2145 2025-0201.pdf,af86fd9628ab8c74fe582ed4e1460605
BCBS_FEP_204124 Genetic Testing for FLT3.pdf,362033ce9d8f4568291a31e3d0b4e756
Dean_HealthPlan_Genetic-Testing-Immune-Rheumatoid-9597.pdf,1a27524c328ffb6c217240d20e29235c
CapitalBC_medical-policy-investigational-miscellaneous-genetic-and-molecular-diagnostic-tests.pdf,353f105ef050247b8a09d927acbd4f71
Asuris_Northwest_Health_Preimplantation Genetic Testing of Embryos.pdf,4b02d08a72e2d67b94a209d29847549d
Blue Cross Idaho_02.04.043_01-30-25.pdf,86d45cd79627355495c21b061a1eee31
Sentara_Genetic Testing—Pre-Treatment or Post-Intervention Commercial - Medical 34B.pdf,30986183e53b914e572f5b08ed7c0b47
BCBS_HW_GTM Laboratory Procedures Reimbursement Policy AHS-R2162 2025-0301.pdf,c878b65b04ab27e730b8b1430da860f4
HealthParners_hearing loss.pdf,77829755fd0b4d30f3bbe680406c2bcf
BCBS_Illinois_SUR703.002_2024-05-15.pdf,ed0febc7c111f39cb0ee760af66f8c0e
FallonHealth_LabPath030125.pdf,bb65843af74eaca1e0b015c690338d8a
Carelon_Amerigroup_BCBSAlabama_Pharmacogenomic.pdf,64bf953fbe0b0ef2c03ff76555435227
Asuris_Northwest_Health_Evaluating the Utility of Genetic Panels.pdf,4c7949ffdf6d3aa1ede9b2474f0cd243
Cigna_MOL.TS_.150A_CMA_for_Developmental_Disorders_and_Prenatal_Diagnosis_eff01.01.2025_pub09.10.2024_1.pdf,dd74cd39fca15b7b0888b16ce1da2014
BCBS_FEP_204114 Genetic Testing for Idiopathic.pdf,3715dd31a1832e8199bfaa53fa3ce2a5
BCBS_Illinois_RX501.104_2025-02-01.pdf,fc02036ea5734022be4fe944588531ce
Dean_HealthPlan_Genetic-Testing-Cardiac-DX-9589.pdf,ebeb1718478a7937faaa864b3f31617a
Capital Health Plan_prenatal_screening.pdf,3bca48859ba442d64970f9cf9a4b73a3
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Gastroenterologic-Disorders.pdf,54395b3d385e3dcae1ae79372ce9432e
BCBS_Kansas_genetic-testing-lynch-syndrome-and-other-inherited-colon-cancer-syndromes.pdf,68e057d339fb368544f843430b34ac02
BCBS_HW_GTM Genetic Testing for Fanconi Anemia AHS-M2077 2023-0601_v2.pdf,347f12bce148caabc411f202a4d55ef5
HealthParners_prenatal cell-free DNA.pdf,0eb751a5af84eb510b6a921a5d07967c
BCBS_FEP_204148 Germline Genetic Testing for Pancreatic.pdf,2cfc38a696a0c68645ee7b07b3b2d2ef
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Multisystem-Inherited-Disorders.pdf,fa5d7e04c0123c545fdd2a1c8b6b1105
BCBS_HW_GTM Venous and Arterial Thrombosis Risk Testing 2025-0201.pdf,dd412fa1c8c9dd6e01678eefacfd1462
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Cardiac-Disorders.pdf,5696bf73ba776cfcbf4f217ef78f6aa4
Summacare_Prenatal Genetic Testing Policy.pdf,0400ac89a435b716d3acce343be30027
BCBS_MA_664 Cardiovascular Risk Panels prn.pdf,6ee6bdc642e0e0d9fae9285ceb53648a
BCBS_Kansas_carrier-screening-genetic-diseases.pdf,0e2dd9d7c4a9c36465524eaa543544b5
ScottandWhite.pdf,8a18b4a0c5a9f7da697b9abb4020d81e
PA Medicaid_V1_07.13.21_FINAL_PA.CP.MP.89 Genetic and Pharmacogenetic Testing_REV_2.26.2021_GK Jr_CLEAN_4.28.2021.CJW (1).pdf,71178a31253f44b5314f1c834748906e
mvp-health-care-medical-policies.pdf,797ad6988008344a1ec6c40f88852dcc
V2. 2023 Concert Genetic Testing Prenatal Diagnosis and Pregnancy.pdf,96f7d030e5b6b68a6296a2a347776ef4
BCBS_NE_X130.pdf,f7fa418975bae383235540f4cae7a4f2
Dean_HealthPlan_Prenatal-Diagnosis-Amnio-9576.pdf,3cd1fdfe5c24a065f83fd7d98aee92a9
Asuris_Northwest_Health_Molecular Testing for Interstitial Lung Disease.pdf,26bb13a04e9cc2b9136c481becc21a07
CapitalBC_medical-policy-genetic-testing-for-hereditary-hemochromatosis.pdf,1c63e16644e438a1319a7e995d2ccfb4
Asuris_Northwest_Health_Gene-Based Tests for Screening- Detection- and Management of Prostate or Bladder Cancer.pdf,ba031376fa7e908daaea4de2ac35b68c
CapitalBC_medical-policy-genetic-testing-for-macular-degeneration.pdf,840375100bf7bc25dea23fc4d2a45adc
BCBS_NE_X117.pdf,89cfbc289eca4ef34c0410efe27f7df4
BCBS_FEP_20463 Use of Common Genetic.pdf,4b04d1c955ceeea0643eabdd3658fa59
BCBS_HW_GTM Liquid Biopsy AHS-G2054 2025-0201.pdf,7d6ce888a074994bc4afce691ca441be
TexasChildrensHealthPlan_TCHP Noninvasive Prenatal Testing (NIPT) Genetic Testing Guidelines.pdf,d6ed521f83c8b0bbf04fd7c682e86681
BCBS_MA_536 Analysis of Proteomic Patterns for Early Detection of Cancer prn.pdf,3cf51cf2a5f6d347d4972b284cf743f5
Cigna_MOL.TS_.215.A_PCA3_Testing_Prostate_Cancer_eff01.01.2025_pub09.09.2024_1.pdf,5e7c1f0778a38805e7a2be6cf952af58
Dean_HealthPlan_Genetic-Testing-Gastro-DX-9593.pdf,90bb4d3720d56e3f81537168b7f2527d
Cigna_MOL.CU_.291.A_Genetic_Testing_for_Known_Familial_Mutations_eff01.01.2025_09.10.2024_1.pdf,8244afb8cc3cd93824415438d0276e5c
Cigna_MOL.TS_.344.A_Chromosomal_Microarray_Solid_Tumors_eff01.01.2025_pub09.11.2024_0.pdf,49b51c0399e5563339f32a9f24f20641
Humana_Genetic Testing for Diagnosis of Inherited Conditions - Medicare Advantage.pdf,f7a1b79df824e082849d5443fd815216
CapitalBC_medical-policy-genetic-testing-lipoprotein-variant-decision-aid-aspirin-treatment.pdf,31869267ac60413543f9050619bd18fb
BCBS_NE_X196.pdf,7a1577fec8ca7a03ab2f38b561ed8ba1
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Hearing-Loss.pdf,bff12fe9895b36280a7d71b93fee934a
BCBS_MN_VI-59-005.pdf,1bfffe1a12ea6f73967276c3df43bd19
CountryCare_Non-Invasive-Genetic-Testing-During-Pregnancy-PA.249.CC-ver-Mar-25.pdf,7af0ac174ed5edbd196804f9f229163e
Neighborhood Health Plan of Rhode island_GeneticTesting2.pdf,81b52fe28e54c23e6b7b528305b6c7fb
Amerihealth_Caritas_NH_ccp1233-genetic-testing-alzheimers-disease.pdf,3d098f37714372b47b278b170513876d
BCBS_FEP_20459 Genetic Testing for Developmental.pdf,8340e5b0ce4959eccfb2cb295edb47f3
Blue Cross Idaho_02.04.083_01-30-25.pdf,331165f67c85a408fc891e5eec88ed52
Driscoll_Genetic-Testing-for-Suspected-Disability.pdf,ac152fb47f0d68f793b459c22c74d2cf
Dean_HealthPlan_Genetic-Testing-Pharmacogenetics-9602.pdf,27f651c30781d93409e498ece13be788
Blue Cross Idaho_02.04.081_07-25-24.pdf,7bea66dba9d7c86e6cad9f2d0c06ad5e
BCBS_NE_V67.pdf,63eb1bc61aa5ee57b0e9bca3c4963900
Humana_Genetic Testing for Hereditary Cardiovascular Disease - Medicare Advantage.pdf,a46ec86ac867fffef70bb07e57e0602c
HealthParners_developmental delay.pdf,be74af13897ea8ca94a334b4a3740dce
HealthParners_pharmacogenetics.pdf,9709c11ccdcf03e9f2ac6a2171f38287
BCBS_Kansas_somatic-biomarker-testing-including-liquid-biopsy-targeted-treatment-non-small-0.pdf,65ae155aef9b56b007795f1d809d53d1
BCBS_NE_V63.pdf,7a2d9fe3278c839da70256bcb0a727a7
Ameriheath_Caritas_OH_ccp1282-genetic-testing-duchenne-muscular-dystrophy.pdf,636749e0ceccdeba285331bcef164182
BCBS_HW_GTM Genetic Testing for Mental Health Disorders AHS-M2084 2023-0601_v2.pdf,b407f7ead63c07e5beba8c58a2cd3144
BCBS_MA_921 Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease prn.pdf,602e8fee2e15f52e9d139a3994dca830
United Healthcare_genetic-testing-cardiac-disease.pdf,f77e783d8f23d96b1932bc0f7cf7e8c7
HealthNewEngland.pdf,5cbc77fd16e13843ea3ab5cc50d545e9
Cigna_MOL.TS_.126.A_Angelman_eff01.01.2025_pub09.10.2024_1.pdf,a12c87a8a1f496caa79269615939922a
Regenece2.pdf,f2ac7fddcef14f85b107e2ef0a257763
BCBS_HW_GTM Use of Common Genetic Variants to Predict Risk of Non-Familial Breast Cancer AHS-M2126 2025-0201.pdf,4771adee7238523166129ce61129c464
Vermont_Hereditary Hemochromatosis for web.pdf,d7b34ba10294e2bbd73ee23b336e0e4a
CapitalBC_medical-policy-genetic-testing-pathogenic-FMR1-variants.pdf,758143f7fc63953e333386e272a7ecfb
BCBS_FEP_204126 Germline Genetic Testing for Gene.pdf,b369a95d80f8ba902a8210ce032fcdd1
Blue Shield of California_Blue Shield of California Promise Health Plan_Blue Shield Genetic-Test-Aortopathies-Connective-Tissue-Disorders.pdf,5117430c67963cdac636e243faa9f250
BCBS_MI3.pdf,82cc511574baa6e52412ba4b5b446ab9
CapitalBC_CHARGE syndrome.pdf,32bcb4037841bf789cd5b865c9dd3cd0
BCBS_FEP_204106 Genetic Testing for Charge.pdf,c867e04bd7218644adedb2d3f2f64c73
V2.2023 Concert Genetic Oncology -  Cytogenetic Testing.pdf,1e6d656d964a9a8032583c6b02be5ac6
V2.2023 Concert Genetic Testing- Hematologic Conditions (non-cancerous).pdf,67212c77b6c735359f1400e8f9c7e7c4
BCBS_HW_GTM Fibromyalgia Testing AHS-M2177 2025-0201.pdf,0fd894773005abcfa964b8cb5f93545d
BCBS_HW_GTM Molecular Markers in Fine Needle Aspirates of the Thyroid AHS-M2108 2025-0201.pdf,35ee5ddc07fd5806b71ffbc8255692bf
BCBS_NE_X159.pdf,451955882ad6f28d81c9c1233f03465e
Amerihealth_Caritas_OH_Genetic Testing (7700).pdf,0dd390f171b32de80c09d946b5e15923
North Carolina Medicaid_1S-9.pdf,678807c83f504304e3ade029f32c5d9c
"V2.2023 Concert Genetic Testing- Metabolic, Endocrine, & Mitochondrial Disorders.pdf",e6bd442e9a9d8e6af8b5a3919d1cb022
Cigna_MOL.TS_.162.A_EOFAD_Genetic_Testing_eff01.01.2025_09.10.2024_1.pdf,3ae3a9206f784653f7a76f753588bf4d
Cigna_MOL.TS_.306.C_Whole_Genome_Sequencing_Cigna_eff01.01.2025_pub09.10.2024.pdf,36bb5264dda1b2027dcdfdd32a714204
BCBS_NE_V36.pdf,20d06535f467b44a6bcd4613bc34021a
Blue Cross Idaho_02.04.107_09-26-24.pdf,ab2baf1876413733417b3f94c38c44fc
BCBS_HW_GTM Genetic Markers for Assessing Risk of Cardiovascular Disease AHS–M2180 2025-0201.pdf,c49b00d679e0d811d9253d3aa8b51136
Blue Cross Idaho_02.04.154_08-29-24.pdf,4a87a6175d17aec3aeb9d79bd9303b3f
Sentara_Genetic Testing - Cardioneurovascular and Developmental Diagnosis Commercial - Medical 34C.pdf,b96c68804845722f10269b6d189f4003
Carelon_Amerigroup_BCBSAlabama_Cell_Free_DNA.pdf,8d73d24c678741ccbe17f06a3c9c7af5
Aetna_Pharmacogenetic and Pharmacodynamic Testing - Medical Clinical Policy Bulletins.pdf,bfc633211a3cc7fe3b90b2fa9212b622
Asuris_Northwest_Health_Gene Expression Profiling for Melanoma.pdf,67106d2d6507d268e03f5240c6ce785f
Dean_HealthPlan_Onc-Cancer-Screening-9606.pdf,08e849b968c7dec94a6c5b6aa187ac33
BCBS_HW_GTM Gene Expression Profiling and Protein Biomarkers for Prostate Cancer AHS–M2166 2025-0201.pdf,0e7a3bcf04b9daf0d1b69c0a8d991335
Ameriheath_Caritas_PA_Genetic_Testing_(7700).pdf,1be3d72b724c0f991c5dd203e44bbfc8
V2.2023 Concert Genetic Oncology- Algorithmic Testing.pdf,4a317ef355ab0695d4c5d4fa4a0363ac
Amerihealth Caritas_Genetic_Testing_(PA02).pdf,107ef045b82e91c90141808a3beda5d5
RockyMountain_genetic-testing-hereditary-cancer-rmhp.pdf,1ddfa71308d53152a22223e77f2cf779
BCBS_NE_X225.pdf,9ecf2e56c7511b8032237a419e4fb1ee
CapitalBC_medical-policy-2-248.pdf,b6eb8e5f70628866e6c7823ade85da1a
BCBS_AZ_gene-therapy-for-cerebral-adrenoleukodystrophy-cald-skysona.pdf,aa01811cb5aa0a79c7d26ef42db0e7c9
Humana_Genetic Testing for Hematologic Malignancies and Suspected Myeloid Disorders - Medicare Advantage.pdf,3bf9a6d9893e82af9f8b27e86d22d22d
BCBS_MA_555 Identification of Microorganisms Using Nucleic Acid Probe prn.pdf,13378f42ae74a6317e6af12b482e87eb
FidelisCareNY.pdf,7169f145f218155aabd6cc352bfe2827
AnthemBCBS_LAB.00044 Saliva-based Testing to Determine Drug-Metabolizer Status.pdf,6ad5eb9ee60d7cd70d5e5ca65faa0727
FallonHealth_InfertilityServices.pdf,fbd5176a9d1503d32fcf51a5714facca
North Carolina Medicaid_1S-3.pdf,0aa5dc62a2b2635084287429a1663a26
BCBS_MA_045 Pathogen Panel Testing.pdf,6598c53e71a0ea29dc2ed5a361afef77
Vermont_Chromosomal Microarray for web_0.pdf,f16ef2be4c74035392d5e4925905fbed
Oregon Medicaaid_HowDoIPayforGeneticServices.pdf,6313c94b70b544d1348738cbb13fa29e
Asuris_Northwest_Health_Expanded Molecular Testing of Cancers to Select Targeted Therapies.pdf,2970d21447303555818837edeecf5cfa
PacificSource Community Solutions_PacificSource Health.pdf,9dae90712ce9ac19b7f046d2438a8c8c
Molina_healthcare.pdf,23816b78c7daebbef645244e5686cae7
BCBS_Kansas_pharmacogenomic-and-metabolite-markers-patients-treated-thiopurines-2023-02-17.pdf,c543aa519078acfbb8fc3fa96db94190
Dean_HealthPlan_Non-invasive-Prenatal-Screen-9573.pdf,36a35c7fde431e5f41f72fd803d93fb2
BCBS_MN_X-45-012.pdf,5ad88762a63beb45815b81166323e544
CountryCare.pdf,83d28fdb5224bad55a41afe065e152eb
IUHP_Genetic-Test-Whole-Genome-Exome-Seq-Policy.pdf,41420e9748d3f610f170ef45dba645a3
CapitalBC_Cardiac ion channelopathies.pdf,4606860bc960102a465397f993250f53
Ameriheath_Caritas_PA_ccp1282-genetic-testing-duchenne-muscular-dystrophy.pdf,59b0b3dcab4f74fd956639ab8f92cc87
BCBS_MA_557 Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening prn.pdf,fb753471c886a21f93786e20295af1fa
Dean_HealthPlan.pdf,44f3fb9a0db48aa4a34b53e769f2362b
Cigna_MOL.TS_.287.A_Hereditary_Pancreatitis_eff01.01.2025_09.10.2024_0.pdf,129edfc2e4309842ece61a0e6d532fdc
Vermont_Cystic Fibrosis Genetic Testing Criteria 04.18.25.pdf,70ab81ca9b6bbce6f5cd29887bc8c04e
Capital_BC_medical-policy-genetic-testing-for-lynch-syndrome-and-other-inherited-colon-cancer-syndromes.pdf,2a82215e210b6e788fa67085a2e5c101
Blue Cross Idaho_02.04.053_11-01-24.pdf,2446c40d23b4d855d664c9d5c190f70e
BCBS_AZ_gene-therapy-for-beta-thalassemia-and-sickle-cell-disease-casgevy-lyfgenia-zynteglo.pdf,8dd18385e5c99777aa563247ef7ab4cf
Asuris_Northwest_Health_Chromosomal Microarray Analysis CMA or Copy Number Analysis for the Genetic Evaluation of Patients with Developmental Delay Intellectual Disability Autism Spectrum Disorder or Congenital Anomalies.pdf,78177462a3a2488aab8e5ff28b9be982
Amerihealth_Caritas_NH_ccp1449-whole-genome-mitochondrial-genome-exome-sequencing.pdf,758a68df332f42cb5772b4c911ab73b3
BCBS_HW_GTM Minimal Residual Disease (MRD) AHS–M2175 2025-0201.pdf,807e4cee8309ad924edf94d5fa3e7f5d
Ameriheath_Caritas_PA_ccp1176-genetic-testing-g1691a-polymorphism-factor-v-leiden.pdf,fea1c7e65d0d6ae613abfaad95a54d87
AnthemBCBS_MED.00148 Gene Therapy for Metachromatic Leukodystrophy.pdf,3b940d1f80e383af6ea389d5da8561eb
BCBS_Illinois_RX501.163_2025-02-15.pdf,4b95eccbdfb3d0e0811db55e3ad66560
Texas Medicaid_2025-07-TMPPM_0.pdf,26230afc3f18d5e6362d0ae4fa77a311
V2.2023 Concert Genetics Oncology-  Circulating Tumor DNA & Tumor Cells (Liquid Biopsy).pdf,1c3f3a024f56fd5c193313ce5d0b1457
BCBS_NE_V65.pdf,40ca59884520d86313980ae0a1c0fcd3
Cigna_MOL.TS_.183.A_Hemochromatosis_Testing_eff01.01.2025_09.10.2024_1.pdf,54b70f95a545084550fb14b05f8c5ca7
Cigna_MOL.TS_.290.A_FSHMD_Facioscapulohumeral_Muscular_Dystrophy_eff01.01.2025_09.10.2024_1.pdf,46fb75c897a1dbe8fa1f0dce2e610aa8
Cigna_MOL.CU_.116.A_Genetic_Testing_via_Multi-Gene_Panels_eff01.01.2025_09.12.2024_0.pdf,64a15be018070bc7e60799cb2718e58b
Blue Cross Idaho_02.04.604_06-27-24.pdf,6855848c9cab191e235c5403ab27161b
BCBS_FEP_204102 Whole Exome and.pdf,d5e9701c13de1dca302ad0ce45524039
BCBS_FEP_20483 Genetic Testing for FMR1.pdf,f34152dde29c2f8e51953668782ed856
Neighborhood Health Plan of Rhode island_GeneticTesting.pdf,03e7525ed981c1a3857df649883fa60a
Health_New_England_genetic-testing.pdf,e55e22fb5c4537a5fa0e7c444f722dff
Dean_HealthPlan_Genetic-Testing-Lung-9599.pdf,b1dca4f6e3f8fa449a1cbaa635a40300
Medica_Genetic-Testing-Pharmacogenetics.pdf,c0574c05e63a8daa48cd434c9f095bbd
BCBS_HW_GTM Prenatal Testing for Fetal Aneuploidy AHS-G2055 2025-0201.pdf,ba02a403f9356dba6fdf549e12820619
Cigna_MOL.TS_.240.A_BCR-ABL_Negative_MPN_eff01.01.2025_pub09.10.2024_1.pdf,4e471414be6b53cae43fe5fea0a7bcb5
Vermont_Trofile Criteria 04.18.25.pdf,dc92915e078f51261ca1788294fbc8c9
BCBS_HW_GTM Genetic Testing for Hereditary Hearing Loss AHS-G2148 2025-0201.pdf,bb2620434bfe76ca413ce28a96061325
Cigna_MOL.TS_.310.A_Ataxia_Hereditary_Ataxia_Multigene_Panel_Testing_eff01.01.2025_pub09.11.2024_0.pdf,1e43e167dba486e633e21583259a81f9
BCBS_FEP_20475 Genetic Testing of CADASIL.pdf,29467c96a52b6982da52e2115afb5f90
Molina_Genetic-Testing_R_Medicaid.pdf,23816b78c7daebbef645244e5686cae7
Aetna_Invasive Prenatal Diagnosis of Genetic Diseases - Medical Clinical Policy Bulletins.pdf,797802684d49252ef06a2a0f1dbee825
Capital Health Plan_BRCA.pdf,7b240d82d705e23d20929b61eb8fb02c
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Dermatologic-Conditions.pdf,bc58e21e9db7280808a681689c757736
BCBS_NE_X205.pdf,412d49205e028331ef8887fe4b53e98c
BCBS_NE_X209.pdf,2317a2535a7f1c500146346b04f44d78
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Hereditary-Cancer-Susceptibility.pdf,8fccc07bd6bae6660c450b75ba9d473a
Cigna_MOL.TS_.144.A_CADASIL_Testing_eff01.01.2025_pub09.10.2024_1.pdf,7a837392b0614102a143694772c9b244
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Prenatal-Cell-Free-DNA.pdf,5d77a802fdf30dfcbb557fc3c68d3175
BCBS_FEP_204154 Germline Genetic Testing for Hereditary.pdf,149a350add72c6c03d60d2544bb1481c
Cigna_MOL.CU_.112.A_Genetic_Testing_for_Prenatal_Screening_and_Diagnostic_Testing_eff01.01.2025_09.12.2024_0.pdf,d68a0f5a769d84cc5743493856cf643d
Dean_HealthPlan_Genetic-Testing-Exome-Genome-9586.pdf,a61f57900019507342ab6d4638abc78c
Blue Cross Idaho_02.04.139_10-31-24.pdf,3bc482386fd8fa150bee9bfff0fd31c2
Asuris_Northwest_Health_Genotyping for 9p21 Single Nucleotide Variants to Predict Risk of Cardiovascular Disease or Aneurysm.pdf,3b12cbe26b0f7f89ec8b229d4337b739
Cigna_MOL.CU_.115.A_Genetic_Testing_to_Predict_Disease_Risk_eff01.01.2025_09.12.2024_0.pdf,f77c2ba1f5eceda651e1d71fb9c005f1
Cigna_MOL.TS_.209.A_Non-Invasive_Prenatal_Testing__Broad_Coverage_eff01.01.2025_pub09.09.2024_0.pdf,4df2062bdfa3216f13a0843e52f946d3
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Prenatal-Preconception-Carrier-Screening.pdf,fa028655e1794a1a98efbccb53e9cd34
Cigna_MOL.TS_.344.A Chromosomal Microarray for Solid Tumors_V2.0.2025_eff07.01.2025_pub04.07.2025_upd06.02.2025.pdf,5d013ddfade368951e1251394f141a31
CapitalBC_medical-policy-genetic-testing-for-inherited-thrombophilia.pdf,677a42ef6747589b2c96b961de6d01a7
Parkland_8-21-2024_genetic-services-biomarker-testing-expanded-c_sabrina-lowery.pdf,ff1bbdd1a2356acda09ba8c091a10ec7
GeisingerHealthPlan.pdf,1bf49b92cc65fbbee9b9064ccdac8d89
BCBS_FEP_20477 Somatic Genetic Testing to.pdf,9c8e24079c2abd7262c27fe55611b12c
Capital Health Plan_genetic_testing.pdf,dc6cbe0afca064303f0c2e7039f5b1b5
Cigna_MOL.TS_.273.A_Hearing_Loss_eff01.01.2025_09.12.2024_0.pdf,7682b5de5f3ac2b04e21ca6e7790870a
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test Preimplantation-Genetic-Testing.pdf,c1c164989aaa90584760533aa6c6b0cf
Dean_HealthPlan_Genetic-Testing-Derm-Conditions-9590.pdf,2df68a54f1dcd29b0f15a801e21ab7d2
Parkland_8-21-2024_genetic-services-biomarker-testing-benefits-f_sabrina-lowery.pdf,2e9c6d1fd0da6c8bd1a1554e9fdd4bb1
Asuris_Northwest_Health_Alpha1 Antitrypsin Deficiency.pdf,91d6888f23ae071e3a10ece5b95b6f41
BCBS_HW_GTM Genomic Testing for Hematopoietic Neoplasms AHS-M2182 2025-0201.pdf,1d59e730d38ad08f24fd71e894a8c2c5
Capital Health Plan_Somatic Biomarker.pdf,afa1b8d31442c36bc3c5b91b994d67c6
Carelon_Amerigroup_BCBSAlabama_Inhertied_Condtions.pdf,bd77fd69eff42182c58832e353124841
North Carolina Medicaid_1S-11.pdf,205d1817ecc4dd451d7561e8bf7067c9
BCBS_MA_283 Novel Biomarkers in Risk Assessment and Management of Cardiovascular Disease prn.pdf,6f4b3208be60f6658ba076b100ae7385
Blue Cross Idaho_02.04.105_02-27-25.pdf,d461a15e90a80c36a81dbda2b50fa481
Blue Cross Idaho_02.04.128_12-19-24.pdf,2872c8dd9d48bf16e30a488aea963b25
BCBS_FEP_20413 Genetic Testing for Alzheimer.pdf,4392b7904103274b3d0ff410e3dfd0ea
BCBS_Kansas_molecular-testing-management-pancreatic-cysts-barretts-esophagus-and-solid.pdf,e34fd096f2b8651b6194b84c598ffbe8
Amerihealth Caritas_NC_1S-11.pdf,205d1817ecc4dd451d7561e8bf7067c9
Cigna_MOL.TS_.217.A_Prader-Willi_Syndrome_Analysis_eff01.01.2025_pub09.10.2024_1.pdf,a90cea87045f1379b300fc5cdae25a37
V2.2023 Concert Oncology- Molecular Analysis of Solid Tumors & Hematologic Malignancies.pdf,8f707705962081e6135306ad38cf6e51
United Healthcare_carrier-testing-for-genetic-diseases.pdf,e4ba24bf5062d995a93a2ef155437c1b
United Healthcare_molecular-oncology-hematologic-cancer-diagnosis.pdf,8834c910b0dfed6badd9e49490deaec9
BCBS_FEP_20482 Genetic Testing for.pdf,6f93a77a34c0f83a2d31ffd88163937b
BCBS_Illinois_PSY301.021_2024-05-15.pdf,29d2c9d8df95bf52921690111c1a69bb
Dean_HealthPlan_Onc-Circultng-Tumor-DNA-Cells-9609.pdf,80034c2e18f67d496f87cd3cc943e1b1
BCBS_NE_V72.pdf,dcbe557aab28599747cdf9a69447b2a9
Asuris_Northwest_Health_Genetic Testing for Diagnosis and Management of Behavioral Health Conditions.pdf,82270ba4d7cbd3527ca1f71815bc3ed4
V2.2023 Concert Genetic Testin- Preimplantation Genetic Testing.pdf,3e815c0bfbe0f161de92ef8b34d4807f
Cigna_MOL.TS_.238.A_BRCA_Analysis_eff01.01.2025_pub09.10.2024_1.pdf,626eac4d60df057ea93ece78f8cc3dfc
BCBS_MA_709 Proteomic Testing for Systemic Therapy in Non-Small-Cell Lung Cancer prn.pdf,cba5121d0c4ab0b1e1b7551378dfa74f
BCBS_Kansas_genetic-and-protein-biomarkers-diagnosis-and-cancer-risk-assessment-prostate.pdf,843dfa80d63b868c2c77dde0ff19dbf3
MarylandPhysicianCare_PA-25-Genetic-Testing-Clinical-Criteria_FINALFeb2021.pdf,20e5c7600177c739236fa176013344bc
BCBS_MA_029 Molecular Testing in the Management of Pulmonary Nodules prn.pdf,40f99eb059ce3c3c56552d1f6f9cfaeb
Asuris_Northwest_Health_KRAS- NRAS- and BRAF Variant Analysis and MicroRNA Expression Testing for Colorectal Cancer.pdf,1f3c1a618ee140467535b5fa27029be5
AnthemBCBS_MED.00140 Gene Therapy for Beta Thalassemia.pdf,61c2306fd8edd79729826c7d735bdcb3
Ameriheath_Caritas_PA_ccp1374-genetic-testing-maple-syrup-urine-disease.pdf,e2ecd1a82f185d3f7f1ddf8c75c0576a
FallonHealth_GeneticTesting.pdf,6727acac8233ac38c2add71406bcdd32
BCBS_NE_V31.pdf,da4dd5f4ff610237540a30b06a923c39
BCBS_FEP_204121 Miscelaneous Genetic and Molecular.pdf,eed6b936395e3651ca847be3063b34f3
Asuris_Northwest_Health_Genetic Testing for Rett Syndrome.pdf,00abf84e9a87896768be57c24f01b0ff
Asuris_Northwest_Health_PTEN_Hamartoma.pdf,194865aac4648c5d7446f3380a1827bb
Blue Cross Idaho_02.04.103_03-27-25.pdf,ec7194e34badd8583229e49727da3332
Sentara_Genetic Testing - Pharmacogenetic Testing Medicaid - Medical 34E.pdf,93e7c619645d80ef63806bb4d2c7e42d
Cigna_MOL.TS_.266.A_Mitochondrial_Genetic_Testing_eff01.01.2025_pub09.12.2024_0.pdf,05d11fa18fd2f79d7752a553947c81dc
Cigna_MOL.CU_.292.A_Genetic_Testing_for_Variants_of_Uncertain_Clinical_Significance_eff01.01.2025_09.10.2024_1.pdf,62303e0548f607f9826eaf511f4680ea
Humana_Genetic Testing for Niemann-Pick Disease - Commercial.pdf,69dbd004cd3bc4ed0520e05999ba2ad8
CapitalBC_medical-policy-genetic-testing-for-fanconi-anemia.pdf,2fbad74d93b805c8e64b7794a0c6f5f1
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Immune-Autoimmune-Rheumatoid-Disorders.pdf,b8b4bbaf577ecb95189f792dfb60d61b
Dean_HealthPlan_Genetic-Testing-Aortopathies-Connective-9588.pdf,d0aa9eec8c4a5036d427e65ad7e7d9d1
Vermont_Fragile X FMR1_050523.pdf,018121a2870b09f88ad0d0b78cf44979
Humana_Genetic Testing for Hereditary Cancer - Commercial.pdf,7d3871265da6338ff34173930d4c8377
HealthParners_exome genome sequencing.pdf,75c1d6336ac56caca13e26a407db7605
Dean_HealthPlan_Preimplantation-Genetic-9574.pdf,d7357c88e3ab96b8dfac5627805b9ab4
CapitalBC_medical-policy-genetic-testing-for-hereditary-pancreatitis.pdf,e431300129d878353d12d699e8a9469d
AetnaBetterHealth_Louisiana_BRCA_Genetic_Testing_and_Counseling.pdf,30e4a543600a2f99bebd6a73c558bd51
Cigna_MOL.TS_.148.A_CMT_Panel_Testing_eff01.01.2025_pub09.10.2024_0.pdf,fa080cad84e1ee37243cc1a00c8607b8
AIHP_Arizona_Medicaid.pdf,c0c3883cb392b61cdfc355f4e8b3cbb5
BCBS_HW_GTM Genetic Testing for Polyposis Syndromes AHS-M2024 2025-0201.pdf,62cdd999cbda12fb14c0f6fa3aee568e
BCBS_Illinois_RX501.098_2024-12-15.pdf,0477aac5345246e9f487d64fbf121090
HealthParners_cardiac disorders.pdf,22a83b30849e3ca545dd46d1f4ae4a4e
Blue Cross Idaho_02.04.582_05-29-25.pdf,4304074d0ab1daf72941b7dc29cda4c5
BCBS_HW_GTM Genetic Testing for Diagnosis of Inherited Peripheral Neuropathies AHS-M2072 2025-0201.pdf,291f5fec924203ca3e77bdf0f40219ee
MarylandPhysiciansCare_Molecular-Genetic-Testing.pdf,fe7cca18541c74e3535ff811af224e8e
HealthParners_aotopathies.pdf,68b4485f413306bc80db7c2fcb572c81
BCBS_HW_GTM Red Blood Cell Molecular Testing AHS-M2170 2025-0201.pdf,b9d2d037e16486fddc2befe18404d1e2
Oscar_CG043_Prenatal_Testing.pdf,c20e636a1a939e8105f40985c97fd4f2
Cigna_MOL.CU_.256.A_Confirmatory_Genetic_Testing_eff01.01.2025_pub09.10.2024_1.pdf,ad0f1d4ff5d23535b2ac86f66e8f4bd9
BCBS_FEP_204150 Serologic Genetic and Molecular.pdf,94294fbe9a089e2a33506845b0b7fdf3
Carelon_Amerigroup_BCBSAlabama_Prenatal_Screening.pdf,ca70dfc81b7c5240ffc2cf422bdd578b
BCBS_MN_VI-32-019.pdf,551465f7e24fdb62d0330b5593d4d979
caresource_Georgia_medicaid.pdf,0adc90552e03b8d520220185df8ee0eb
Sentara_Genetic Testing-Cardioneurovascular and Developmental Diagnosis Medicare - Medical 34C.pdf,7bbf71e01aa3ea1d9813dfe7cb88899a
BCBS_NE_X171.pdf,5735980508707809325ea448700f584e
Aetna_Hematopoietic Cell Transplantation for Inherited Metabolic Disorders and Genetic Diseases - Medical Clinical Policy Bulletins.pdf,da1b882f1ab2a79f4c39a8e72989fba3
Blue Cross Idaho_02.04.077_10-01-24.pdf,2b04ed17e5615bd2b451d28df182e140
AnthemBCBS_MED.00120 Gene Therapy for Ocular Conditions.pdf,fc42fc6c34b0607bc54ba933400f2805
Asuris_Northwest_Health_Alzheimer.pdf,2b59a768b4bdd351ec9e8503a0d210f7
Asuris_Northwest_Health_IDH1_2.pdf,ea18919d30b556e4ce8465f63e1f9b6a
HealthAllianceMedicalPlans.pdf,8bbc75cff8046bf853bb9faaadc007f4
BCBS_HW_GTM Genetic Testing for FMR1 Mutations AHS-M2028 2023-0601_v2.pdf,480c20428879a87b34923302c3380583
BCBS_NE_V30.pdf,363e814a53a95a95b0a57a4b6f813d27
HealthParners_epilepsy neurodegenerative and neuromuscular disorders.pdf,d22df416b19661da682e7740bf52833e
BCBS_NE_V69.pdf,67b581bec5dd5c6c78f4bd32380a7cb0
Carelon_Amerigroup_BCBSAlabama_Hereditary_Cancer.pdf,76b23a70ff9c6970063e4040c5f50c4d
BCBS_MA_702 Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases prn.pdf,c23c6073df561282200bf4144efb1191
Ucare_covpol_preventativeservices.pdf,28c5b117264c0ec294e5b1a420bd1ac6
BCBS_NE_X169.pdf,e0a97e37e48ff0bc287eadabbded9612
AnthemBCBS_LAB.00045 Selected Tests for the Evaluation and Management of Infertility.pdf,7258de84f1cc8eca132f7c06b81d7f16
"Humana_Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer - Commercial.pdf",543c598bf6aa473feb8db3c889263451
Asuris_Northwest_Health_Biallelic RPE65.pdf,f06143677e29d1f0ef8e115f72506964
Cigna_MOL.CU_.246.A_Germline_Test_After_Somatic_Testing_eff01.01.2025_pub09.10.2024_upd11.18.24_1.pdf,53a4d4077f2da715e1953d9584eae5ae
BCBS_HW_GTM Testing for Targeted Therapy of Non-Small-Cell Lung Cancer AHS-M2030 2025-0301.pdf,0446f5358325e177b887bbf227296657
Sentara_Genetic Testing—Pre-Treatment or Post-Intervention Medicaid - Medical 34B.pdf,c4eb075aeab16f8488a298246054beeb
BCBS_NE_V62.pdf,41e2dae5d0b2174e1c522cde81df5332
North Carolina Medicaid_1S-1.pdf,e3adf0c3d3ed335e76eb6ef2ef3e979a
oxford_preimplantation-genetic-testing-and-related-services-ohp.pdf,52c24e84ffbdc84e1a026341fa170d53
North Carolina Medicaid_1S-10.pdf,4c703ffc7d934f5fc924b92bb54fdf52
North Carolina Medicaid_1S-12.pdf,4398a799f9189884c3fea99eebbd662e
Cigna_MOL.TS_.267.A_Ehlers-Danlos_Syndrome_Genetic_Testing_eff01.01.2025_09.12.2024_0.pdf,e92f70f171fcdf22aa7f2df3cfac5780
Asuris_Northwest_Health_Primary_Mitochondrial_Disorders.pdf,cc313b53a9166272890df2774d99bda3
CapitalBC_medical-policy-genetic-testing-for-PTEN-hamartoma-tumor-syndrome.pdf,005a6c7d87d072f0cbaf9488a89eec37
Asuris_Northwest_Health_Whole Exome and Whole Genome Sequencing.pdf,d311253a9fd61d206867e61ccdc8b22c
Ucare_ifp_fetalaneuploidy.pdf,7c7d4d4d1ec70e3fb68de563069e4d4f
BCBS_FEP_204105 Genetic Testing for Facioscapulohumeral.pdf,68e7bacc6a93314a1ac205c71346d8b6
Medica_Genetic-Testing-Hereditary-Cancer-Susceptibility.pdf,82507eb963898efcd50cf536e30852b6
Asuris_Northwest_Health_Genetic Testing for Duchenne and Becker Muscular Dystrophy.pdf,2af167c6085ee7006d3b93239962ed2d
AnthemBCBS_LAB.00011 Selected Protein Biomarker Algorithmic Assays.pdf,089d484095fa455a1af09821b579fc26
Empire BCBS_reimburse.pdf,c7176942015d7f1dcdf3403cadfd181c
Asuris_Northwest_Health_Gene Expression Based Assays for Cancers of Unknown Primary.pdf,b11433e4ef2adc12ed1c93bb78acb100
Cigna_MOL.TS_.206.A_MUTYH-Associated_Polyposis_Genetic_eff01.01.2025_pub09.10.2024_0.pdf,5d18f6f55342227cde39e87366e48528
BCBS_FEP_204129 Genetic Testing for Marfan.pdf,1b0ed4a6056fb8b077b861edbef9b6c6
United Healthcare_genetic-testing-hereditary-cancer.pdf,c69485372670ce1d12aa8f61d83a06fd
Humana_Genetic Testing for Celiac Disease - Commercial.pdf,9fc7eda4e996acc79c357e6824b4699d
United Healthcare_genetic-testing-neuromuscular-disorders.pdf,4dec1a815b8ecffdf00d34ad7f04836f
V2.2023 Concert Genetic Testing- Cardiac Disorders.pdf,c05a961f53efe2518524af2c083304f2
CapitalBC_medical-policy-genetic-testing-for-marfan-syndrome-thoracic-aortic-aneurysms-and-dissections.pdf,5d41c1cce883c900983c8e5ea597c349
oxford_genetic-testing-neuromuscular-disorders-ohp.pdf,0c988c1557f7c1a3738fcf9786bbd324
Ameriheath_Caritas_PA_ccp1233-genetic-testing-alzheimers-disease.pdf,097bdb9313a98447447179d8f90ec9d9
CapitalBC_Mental health.pdf,74139a574f1b14006e397ed87b4da53a
Cigna_MOL.TS_.359.A_IBD_Biomarker_testing_for_inflammatory_bowel_disease_A_eff01.01.2025_pub09.11.2024_0.pdf,479a27781ef75f521fb65fe93392141f
oxford_gene-expression-tests-cardiac-conditions-ohp.pdf,769127f8bd86f1ef9fa1b9a609ff6e74
BCBS_HW_GTM Pancreatic Cancer Risk Testing Using Pancreatic Cyst Fluid AHS-M2114 2023-0601_v2.pdf,8af6dd2d463caad9db20670c6459a615
BCBS_HW_GTM Genetic Testing for Neurofibromatosis and Related Disorders AHS-M2134 2025-0201.pdf,c3ae8eb19ef17f038d5ab5c56eee1781
Blue Cross Idaho_02.04.080_05-29-25.pdf,a78fae974caa14fb830fab95b9504bdb
Cigna_MOL.CU_.117.A Investigational & Experimental Mol Gen Testing_eff01.01.2025_pub09.12.2024_upd11.18.2024_0.pdf,73398d6bc58c5274ad4f10e7c7def699
BCBS_NE_V57.pdf,1c7ff33d18707764785001739fb335dd
BCBS_HW_GTM Genetic Testing for Familial Hypercholesterolemia AHS-M2137 2025-0201.pdf,4312511e1c3f80f0eb0b5cc1c9a3e9b2
Humana_Genetic Testing for Hereditary Cancer - Medicare Advantage.pdf,346f248c86fe2d5a210cbd5449197dc4
Humana_Genetic Testing for RASopathy Syndromes - Commercial.pdf,56b4a190b5b6ff23f911bf07099eda2a
BCBS_HW_GTM Genetic Testing and Genetic Expression Profiling in Patients with Uveal Melanoma AHS–M2071 2025-0201.pdf,d5bd45ccfcfe85846b38d6d2b82cb6c0
Cigna_MOL.TS_.302.A_SPRED1_Legius_Syndrome_Genetic_Testing_eff01.01.2025_pub09.10.2024_1.pdf,8c856dd132280f9f46289991d7e30f24
CapitalBC_medical-policy-genetic-testing-for-the-diagnosis-of-inherited-peripheral-neuropathies.pdf,92afe5df24e43d420a3bbd85584b75c0
HealthPartners.pdf,7c0799d8cd54926f2eed0f4b50e5983c
BCBS_HW_GTM Chromosomal Microarray AHS–M2033 2025-0201.pdf,505d793afd30223304a44a808b8b6a79
BCBS_HW_GTM Genetic Testing for Familial Cutaneous Malignant Melanoma AHS-M2037 2023-0601_v2.pdf,2c2d822273b3da76275c6b6b3b531364
BCBS_HW_GTM Multigene Expression Assay for Predicting Colon Cancer Recurrence AHS-M2111 2023-0601_v2.pdf,8c4e910939a990bc0bf799202b01c80d
BCBS_FEP_20436 Assays of Genetic Expression.pdf,223feb6250516fc9ebd75361f5b0cf75
Vermont_Hereditary Breast and Ovarian Cancer criteria for web.pdf,25fab4cbf403683aa1adbd412fd140e1
Cigna_MOL.CU_.113.A_Genetic_Testing_for_the_Screening_Diagnosis_and_Monitoring_of_Cancer_eff01.01.2025_09.12.2024_0.pdf,01450a1d59b894b8ff7f5fdddc323cfb
V2.2023 Concert Genetic Testing- Hearing Loss.pdf,dbb025843065de8682ff5caf15826ac6
SharpHealthPlan_p5-preventive-services.pdf,8c30e112a784ef59ef1d410a99a51ff3
Carelon_Amerigroup_BCBSAlabama_Polygenic.pdf,50c2a99b0be08af4ca165fecfc4e1b03
Dean_HealthPlan_Genetic-Testing-Eye-9592.pdf,c7535c6466292a351583942428fe1f23
"Humana_Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer - Medicare Advantage.pdf",24a3f6c4d04373ed88dd43daea8ea313
CapitalBC_medical-policy-genetic-testing-for-limb-girdle-muscular-dystrophies.pdf,8baec81857baf104a77271a1eef23bd5
CalOptima_genetic.pdf,ab5247c345b98b38b915b27b46412a8b
Oregon Medicaaid_Prioritized-List-Prenatal-Genetic-Testing.pdf,10fbb9baf2a470f3cf666f80dba660e7
Cigna_MOL.TS_.251.A_PALB2_Genetic_Testing_eff01.01.2025_pub09.10.2024_1.pdf,2c7426f5a7c6eabe7d9b19ab756f8a88
BCBS_Kansas_genetic-testing-diagnosis-and-management-mental-health-conditions.pdf,73292950d4fd0362a9705e887d147501
BCBS_NE_V66.pdf,81fab13bdd9494e4fed2a52240c9d8e9
BCBS_FEP_20486 Genetic Testing for Duchenne.pdf,4298745a9e26907c455aca462e6cba47
Vermont_COU Human Platelet Antigen Genotyping for web.pdf,c11cdcc08bf653cfd10a689ac6134e15
CapitalBC_medical-policy-genetic-testing-for-epilepsy.pdf,105131243cab907224770e9c99545d61
BCBS_MN_VI-08-013.pdf,2c5e94272d45ff08923d6a6eb871994f
Cigna_MOL.TS_.230.C_Somatic_Mutation_Testing_Cigna_eff01.01.2025_pub09.20.2024_upd11.18.2024.pdf,38111d526fd7e5fd8a76a816ab52e297
Oxford_molecular-oncology-hematologic-cancer-diagnosis-ohp.pdf,b51ad8b4e18d4538661e3c77c53563f9
BCBS_FEP_20479 Genetic Testing for Alpha.pdf,47101484b0ad6f75e492fab20c2ad6de
Dean_HealthPlan_Genetic-Testing-General-Approach-9610.pdf,55068b1c3865dd5fa33cd7009645f030
BCBS_MA_165 Laboratory Testing Investigational Services.pdf,976d51125e276c555471243bf0f27862
BCBS_HW_GTM Transplant Rejection Testing AHS-M2091 2025-0301.pdf,7fcd2c790cb8bef103d071d3ede66766
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Exome-Genome-Sequencing-DX-Genetic-Disorders.pdf,4a67ab8d638a46c1cd4205ca5af48ae4
Ameriheath_Caritas_PA_ccp1198-genetic-testing-sensorineural-hearing-loss.pdf,d4e0e868d0713f9df16c1377ad50e578
BCBS_Illinois_SUR716.015_2025-02-01.pdf,d68c6d35014aac3dc02909825fac980b
Asuris_Northwest_Health_Targeted Genetic Testing for Selection of Therapy for Non-Small Cell Lung Cancer -NSCLC.pdf,736e652cb33bba26094502ee363ff519
Cigna_MOL.CU_.119.A_Preimplantation_Genetic_Diagnosis_eff01.01.2025_pub09.10.2024_1.pdf,35e92dddac0175699f20e8ac56693543
Asuris_Northwest_Health_Genetic Testing for Familial Hypercholesterolemia.pdf,864e9e8da31dc137a67bb4a4a2bd6b59
BCBS_Illinois_RX501.151_2024-07-15.pdf,e39a04f70b02be573f92f26f1d5a71ef
BCBS_FEP_204137 Genetic Testing for Neurofibromatosis.pdf,48514d63df3ec4612fa4f460082ecd1b
Asuris_Northwest_Health_Identification of Microorganisms Using Nucleic Acid Probes.pdf,3ed0f29bbd7f1f951b12e0f31095cec0
BCBS_HW_GTM Genetic Testing for Hereditary Hemochromatosis AHS-M2012 2023-0601_v2.pdf,dedd8dc76c0e2baa98bfaa6e1ecc883c
HealthParners_oncology_cancer_screening.pdf,744870afb12d49779ed4f4e074be3223
Blue Cross Idaho_02.04.002_08-29-24.pdf,ae3960b87d83b6aec81f2a5663dea2a5
Harvard Pilgrim Health Plan_Tufts Health Plan_WGS_THP-Commercial-MNG.pdf,f67a1425df25c108c4eee8dcfc3a0dc8
CapitalBC_BRCA.pdf,34dc0823a03ca2f20ba740345d7b57da
BCBS_HW_GTM Genetic Testing for Connective Tissue Disorders AHS–M2144 2025-0201.pdf,d7505a2f890b658493d3a7cc53d2d1ad
Harvard Pilgrim Health Plan_Tufts Health Plan_Genetic-Testing-Prenatal-Diagnosis-Carrier-mng.pdf,d544d22fd03d9c4f53649b8e904a7151
Cigna_MOL.TS_.360.A_IBMFS_Inherited_Bone_Marrow_Failure_Syndrome_Testing_Panel_eff01.01.2025_pub09.11.2024_0.pdf,3a3635b3c2926cba1b6e7359c2b06096
Amerihealth_Caritas_NH_ccp1050-familial-polyposis-gene-testing.pdf,d6ae42af1aca0b25f44347f46c87df7f
Asuris_Northwest_Health_topographic_Genotyping.pdf,a7b1771ecb9f3850b8c8e652f973bb43
BCBS_FEP_204117 Genetic Testing for Mitochondrial.pdf,e1ff5725be63fb96168f31308165494e
United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,4fadf6b3ca9d4d08131cb31365e3aa7d
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-General-Approach-Genetic-Molecular-Testing.pdf,e14bc0a1fa9f6d20f02add028c8afc9b
BCBS_Illinois_RX501.146_2024-07-15.pdf,05ef9720a25b931a47be5b3ad4c1d2fc
Amerihealth Caritas_NC_1S-10.pdf,4c703ffc7d934f5fc924b92bb54fdf52
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Pharmacogenetics.pdf,de1be307c46621d86af8fe675882431c
Ameriheath_Caritas_PA_ccp1475-genetic-testing-epilepsy-seizure-disorders.pdf,feb43de40f9b8142b7ec3dbda119de10
Cigna_MOL.TS_.235.C_Whole_Exome_Sequencing_Cigna_eff01.01.2025_pub09.20.2024.pdf,ad2eb3a750b767e32ff847032f0e8e03
Ucare_covpol_fetalaneuploidy.pdf,29ee54faca9f31b9e095a885ae4e96c2
TexasChildrensHealthPlan_Genetic Testing Guidelines_0.pdf,67c731f956a9ad8c19207544a71e9055
BCBS_NE_V71.pdf,bc920a4d9ab78a732f9843d33fe65336
Humana_Genetic Testing for Disease Risk - Commercial.pdf,0bdd32e0213ff2e0602b62ab49079188
BCBS_MN_VI-56-013.pdf,d00b753c79346c2c355b6486384d5f79
Carelon_Amerigroup_BCBSAlabama_Carrier_Screening.pdf,a3770a91005a122754b985c8a465db60
Cigna_MOL.TS_.182.A_Hereditary_Cancer_Syndrome_Panels_eff01.01.2025_pub09.10.2024_upd11.18.2024_1.pdf,f86edbfcfebab5398e047bdf691dca25
HealthParners_dermatologic.pdf,21ec1794a481f5e8dadfb3568f20068c
BCBS_HW_GTM Therapeutic Drug Monitoring for 5-Fluorouracil AHS-M2067 2025-0201.pdf,e9a66c4d1367a92a76a420b3938637af
Asuris_Northwest_Health_Inherited_Peripheral_Neuropathies.pdf,ef7f4d75c4932d218e6aa72957ff8e1b
BCBS_NE_X75.pdf,5913937b80e8aa0a7472973a93f1b022
Cigna_MOL.TS_.276.A_POLG_eff01.01.2025_pub09.12.2024_0.pdf,d68f4b839c21935b5716ca7dbf24f4b5
BCBS_MA_088 Preimplantation Genetic Testing prn.pdf,e67936c5ac5600a304de44716975e98f
BCBS_HW_GTM Genetic Testing of Mitochondrial Disorders AHS-M2085 2023-0601_v2.pdf,48199cc7946b1221e39a2ed8d0f8c0d5
BCBS_Kansas_biomarker-testing-risk-assessment-and-management-cardiovascular-disease.pdf,829c8a109087cee4f00fbabb7b8d9c49
BCBS_AZ_gene-therapy-for-severe-hemophilia-a.pdf,eac68cfe9e762b356cf82af172c957c4
Dean_HealthPlan_Genetic-Testing-Inherited-Intell-Develop-9587.pdf,5871e14fe39fd5aa15831fb57db23c5b
BCBS_NE_V61.pdf,f22f79fdbee8b0bb343d132d093a0216
BCBS_Illinois_RX501.122_2024-12-15.pdf,768c8946dfd2c281d01b85bdb0aca985
BCBS_NE_X216.pdf,8de2464d2b6feb17b34afdb4091ce995
Vermont_TUMOR PROTEIN 53 Genetic Testing TP53 for Li-Fraumeni 083024.pdf,7c7cc2533a69687d96558b9dda47ac00
HealthParners_molecular analysis.pdf,b1c43ac913324c6d8481a7cbbdc82d0a
V2.2023 Concert Genetic Testing- Gastroenterologic Disorders (non-cancerous).pdf,38d83307e8a5edcd3b967ecc4113fcc6
Cigna_MOL.CU_.111.A_Genetic_Testing_for_Non-Medical_Purposes_eff01.01.2025_09.12.2024_0.pdf,bcd33b7fc6f3d9c65e34d9efbd84d92f
Cigna_MOL.TS_.232.A_VeriStrat_Testing_eff01.01.2025_pub09.10.2024_1.pdf,0df3c01884810321ef0636845d8fe3d0
Cigna_MOL.TS_.158.A_Cystic_Fibrosis_eff01.01.2025_pub09.10.2024_1.pdf,e5206667ddcceccedee5034c63f3eafa
BCBS_FEP_204110 Genetic Testing for Diagnosis.pdf,cd0e7f6bbe1b36a0e984a28614c79b17
Cigna_MOL.TS_.223.A_PHTS_eff01.01.2025_pub09.10.2024_1.pdf,f8782b112e275d9930e4b4b6b3808eb1
Dean_HealthPlan_Genetic-Testing-Cancer-Suscept-9596.pdf,99a73c49347a68b491fd32bbac570be8
BCBS_HW_GTM Microsatellite Instability and Tumor Mutational Burden Testing AHS-M2178 2025-0301.pdf,78eca719a209d81b1b15abe2ae235177
BCBS_Kansas_identification-microorganisms-using-nucleic-acid-testing.pdf,ce1054c1330be18d92807c1fb91052ac
Cigna_MOL.TS_.202.A_Marfan_Syndrome_Genetic_Testing_eff01.01.2025_pub09.10.2024_0.pdf,6d7554732a916ed15c8d075c37431c31
BCBS_FEP_20488 Genetic Testing for PTEN.pdf,7b57b82fe8728e00fb71a7ff88c354c0
Mass General Brigham Health Plan.pdf,6ee9fcac102cb43df04fb3003fc3a0f3
Dean_HealthPlan_Genetic-Testing-Metabolic-Endocrine-9600.pdf,2e6e3ad280feaf55fd4936d3c71ace66
Aetna_Celiac Disease Laboratory Testing - Medical Clinical Policy Bulletins.pdf,1ac19909d483881ca116b770670737d3
Dean_HealthPlan_Onc-Cytogenetic-Test-9607.pdf,c895c2fe131561e84e68f1d0bbcd2042
CapitalBC_whole-exome-and-whole-genome-sequencing-for-diagnosis-of-genetic-disorders.pdf,a73b8a2ce768f28198cd9450f3858945
Dean_HealthPlan_Genetic-Testing-Kidney-9598.pdf,c28638e2ce86cd8070166067cc6de3b0
BCBS_NE_V75.pdf,6fb03a9d0a2fa2e1df00c2416170af8d
HealthParners_hematologic disorders.pdf,4d4c3de16f661c0c328e0314258fe3b2
Cigna_MOL.TS_.269.A_Autism_eff01.01.2025_pub09.12.2024_0.pdf,294644a4d7e140dd752aaa942f412236
Asuris_Northwest_Health_Genetic Testing for Epilepsy.pdf,531d937c25cb8020b18393d58cf7dc23
Amerihealth_Caritas_NH_ccp1374-genetic-testing-maple-syrup-urine-disease.pdf,0aed54d3d4ce15427950ac251c0aa6fe
BCBS_HW_GTM Genetic Testing for Epilepsy AHS-M2075 2025-0201.pdf,820ef7d255652951b18da901c4d26287
Vermont_Noninvasive Prenatal Testing or Serum Marker Screening for Down Syndrome for web.pdf,52f66ecd8d181eb379ef4e878a8e443e
Humana_Genetic Testing for Diagnosis of Inherited Conditions - MEDICAID -FLORIDA.pdf,6745b514466a0c060d96bf1c5484c2ae
Dean_HealthPlan_Genetic-Testing-Hearing-Loss-9594.pdf,75bb527af4e1849d47e7e516005ea3a8
Parkland_8-21-2024_genetic-services-biomarker-testing-whole-geno_sabrina-lowery.pdf,2e8b371bc1cea3c6f48192d2935de67c
Cigna_MOL.CU_.118.A_Pharmacogenomic_Test_Drug_Toxicity&Resp_eff01.01.2025_pub09.10.2024_upd11.18.2024_0.pdf,a381da0ec6f5ada67a7efbac56053522
Washington Medicaid_Genetic_Testing_Policy_Clinical_Coverage_Criteria_-_MM165.pdf,e333b2eab6adeaff935bc9915c8c7699
United Healthcare_chromosome-microarray-testing.pdf,8a7d5f974648c666b635eae9e03277e7
V2.2023 Concert Genetic Testing- Kindey Disorders.pdf,4d6e07b21416446b6a122f74b6566b44
CapitalBC_medical-policy-genetic-testing-of-cadasil-syndrome.pdf,d7c339efa02a877fc2904228bb4f29a4
AnthemBCBS_MED.00146 Gene Therapy for Sickle Cell Disease.pdf,5a4f5b216740f9da451598e2631bf661
BCBS_MN_VI-16-014.pdf,c1dffcd70f96f68e083b8a2cab556fb8
V2.2023 Concert Genetic Testing - Immune Autoimmune & Rheumatoid Disorders.pdf,9380458961de1e8c81beafdc68c32955
Driscoll_Using-Large-Genetic-Testing-Panels.pdf,61263ce8955e5449356c67ed9b7f5482
BCBS_NE_V74.pdf,5eadb90735e23420b14c966abf3ed9bd
HealthParners_cytogenetic testing.pdf,5e4cbb441ecc080ee16eb35ab6d07443
Humana_Genetic Testing for Diagnosis of Inherited Conditions - Commercial.pdf,864f3d1c2e7af6d1e681c076618118d9
Blue Cross Idaho_02.04.059_10-31-24.pdf,83b214dc12fbba0380efee3d888dd643
Humana_Genetic Testing for Hereditary Peripheral Neuropathies - Commercial.pdf,61f0d0f8b41f74d9449807ebf8d46145
BCBS_HW_GTM Testing for Autism Spectrum Disorder and Developmental Delay AHS-M2176 2023-0601_v2.pdf,842cd346aab0fb66ca8877afa7c64c9d
Sanford_moldx-genetic-testing-for-hypercoagulabilitythrombophilia-fv-leiden-fii-prothrombin-and-mthfr-111201.pdf,43a395bc4911bfaf445adf6854e51228
Cigna_MOL.TS_.193.A_li_fraumeni_eff01.01.2025_pub09.10.2024_1.pdf,85f13aabc485ef041f04b232b2cbe275
Humana_Genetic Testing for Hereditary Ataxias - Commercial.pdf,fc03504efec73d9a27baea4d25a20c8b
BCBS_HW_GTM Testing of Homocysteine Metabolism-Related Conditions AHS-M2141 2023-0601_v2.pdf,a0178fa903bc7a86a6a108db195d569b
BCBS_HW_GTM Genetic Testing of CADASIL Syndrome AHS-M2069 2023-0601_v2.pdf,6d11620da4fd674e6da5f7fa0c1641d6
Humana_Genetic and Coagulation Testing for Noncancer Blood Disorders - Medicare Advantage.pdf,f6b6bc8daf3a9d3e3e5c832035b65ac5
Commonwealthcare_genetictesting.pdf,c08098003deb78ab5c35dff31180ba28
BCBS_HW_GTM Genetic Testing for Lactase Insufficiency AHS-M2080 2025-0201.pdf,a5e13f411027350871c6052398b9cfb0
BCBS_MA_581 Evaluation of Biomarkers for Alzheimer Disease.pdf,4dc0efc12c944e08df8b200e5ba6106e
Asuris_Northwest_Health_CADASIL Syndrome.pdf,106b7ffcc68a3798183af2d561083b94
DevotedHealth_Molecular-Testing-Review-Criteria.pdf,492957e2cf1246a955722d273f391d90
Asuris_Northwest_Health_Cytochrome p450 and VKORC1 Genotyping for Treatment Selection and Dosing.pdf,f21da805765e52c0d8d16d1b21327374
BCBS_HW_GTM Genetic Testing for Alpha- and Beta-Thalassemia AHS-M2131 2025-0201.pdf,32cfafda02ddc809b68c2b1dff6faac9
PriorityHealth.pdf,a29c046e59c6ce7d1428836dc480e456
Blue Cross Idaho_02.04.088_02-27-25.pdf,7fb1c3a988b17a4e3af829cae98d5390
BCBS_HW_GTM Mutation Analysis in Myeloproliferative Neoplasms AHS-M2101 2025-0201.pdf,36ab511bd23d3333b333ecae793aed16
CapitalBC_medical-policy-genetic-testing-li-fraumeni-syndrome.pdf,8c80f665450d7142bda50d7854c4817b
BCBS_FEP_204104 Genetic Testing for.pdf,b4f1d96c05c1092860c767df91d889fa
Cigna_MOL.TS_.225.A_Spinal_Muscular_Atrophy_eff01.01.2025_pub09.10.2024_1.pdf,239ad766cd988f1b720688f840add775
caresource_market_genetictesting.pdf,974232454e6594e1608a17af58756ded
BCBS_HW_GTM Genetic Testing for Hereditary Pancreatitis AHS-M2079 2025-0201.pdf,f5534b286a192846eb77adabdb2ab970
AnthemBCBS_LAB.00036 Multiplex Autoantigen Microarray Testing for Systemic Lupus Erythematosus.pdf,a34901c67643cb2f4e69a0c66a0b28ab
BCBS_NE_X168.pdf,fb29603abb918880c6f3922bb838438d
BCBS_Illinois_RX501.139_2024-06-15.pdf,1c4fd34b3c725d89251255c2ed61f759
Vermont_COU Allomap for web_0.pdf,c2c11ec3b9808fc49862c4cf39ebcc1b
BCBS_NE_M9.pdf,19403c90b1b3db626bd01429f5c78610
Health Partners Plan_mn011d-whole-genome-whole-exome-sequencing.pdf,c4e271bca788c1bc5741f30129b22b32
BCBS_HW_GTM Whole Genome and Whole Exome Sequencing AHS-M2032 2025-0201.pdf,5c3e9f5caa43bdf48f016eb466a557d1
tricare_west.pdf,4b65fe252ddd65774712d71b3ae71569
Humana_Genetic Testing for Hereditary Colorectal and Uterine Cancer - Medicare Advantage.pdf,46e95fe4151df903445136540124e7ee
Asuris_Northwest_Health_Fetal Red Blood Cell Antigen Genotyping Using Maternal Plasma.pdf,2f1a8378771b40c663071f9d1d0ca132
Cigna_Carrier_Screening_Panels_Cigna_V1.0.2025_Eff02.10.2025_pub02.07.2025_0.pdf,19f3f45b1ac0c44ca0b7ed485235739e
Blue Cross Idaho_02.04.087_04-24-25.pdf,f1facb0edab3a833c6815de63b1727a6
BCBS_HW_GTM Esophageal Pathology Testing AHS-M2171 2025-0201.pdf,2425c3c727692c7f21259c50a709bf80
Asuris_Northwest_Health_FMR1 AFF2.pdf,b603f49fdab95ce68c9ee6d56a7e96c9
V2.2023 Concert Genetic Testing- Pharmacogenetics.pdf,014c168e0d1e4c93ae7916118c917b5a
Oxford_carrier-testing-genetic-diseases-ohp.pdf,dae617425e0456ebba28c265f0ad8263
tricare_genetic_testing_policy.pdf,9945ac74c7b106334ac3e3095322ad61
BCBS_AZ_gene-therapy-for-aromatic-lamino-acid-decarboxylase-aadc-deficiency-kebilidi.pdf,0ab91d9e10bd1c03f9d2f70072cb18b1
Amerihealth_Caritas_NH_ccp1176-genetic-testing-g1691a-polymorphism-factor-v-leiden.pdf,b1ab58d7e4881affa634420c244ab0b9
BCBS_Kansas_kif6-genotyping-predicting-cardiovascular-risk-andor-effectiveness-statin-therapy.pdf,7cbaf12a96efccbd690fed510dbee24d
Asuris_Northwest_Health_Macular_Degeneration.pdf,a120975a9ec40defc920ec74dc2b64f7
Amerihealth Caritas_NC_1S-9.pdf,678807c83f504304e3ade029f32c5d9c
Cigna_MOL.TS_.228.A_Tissue_of_Origin_Testing_eff01.01.2025_pub09.10.2024_1.pdf,9e165221abc8f304ea8da4072698746a
Utah Medicaid_Documents_manuals_pdfs_Medicaid+Provider+Manuals_Physician+Services_Physician+Services+Manual_PhysicianServices.pdf,19f3f6fcc726caffc935a20eec6afc0f
BCBS_NE_X236.pdf,27994d3aed349ab3dc0c140dd0a35e4c
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Metabolic-Endocrine-Mitochondrial-Disorders.pdf,5d93a8775bf55c4fad5bcd7ba8d8d065
HealthParners_hereditary cancer.pdf,8dae2010aebc3aa8ce9c777f615cb904
CapitalBC_medical-policy-2-361.pdf,86ed97938b0675bbf4e6618de2284a9a
"Sentara_Genetic Testing-Cancer Prevention, Diagnosis and Treatment Commerical - Medical 34A.pdf",870eb5f206b40b1ebb6e70d68607c09c
BCBS_NE_V76.pdf,9ac0fefbd34b953692ba4aecde8ed117
Cigna_MOL.TS_.268.A_HCTD_Policy_eff01.01.2025_pub09.12.2024_0.pdf,38f5b50464df6000c802b594cbed9376
BCBS_HW_GTM Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment and_or CVD Risk Assessment AHS-M2082 2023-0601_v2.pdf,4bd935ed5641290484aeab1104d50c42
BCBS_FEP_20496 Genetic Testing for Statin.pdf,0baca749d71282aafc4f411687a53b63
Healthfirst_Allergen Testing.pdf,79b76a0bd936fec59dd29bb2af603a88
BCBS_NE_V58.pdf,bb631b227aa92d8c0ac707b148df6529
V2.2023 Concert Genetic Testing - Hereditary Cancer Susceptibility.pdf,251f63eaf6f9b3be9e79531678a04927
Oxford_molecular-oncology-testing-cancer-dx-prognosis-tx-decisions-ohp.pdf,8c06999524a9ac31eef6cf20d931c610
Blue Cross Idaho_02.04.089_01-30-25.pdf,9865bb5fbaa2764635f03bac64ba72f3
Vermont_Huntingtons Disease Genetic Testing 083024.pdf,eee8d04dee693d22595fbb3e50d4dc11
Highmark_Delaware.pdf,44df0046f3e41958aa62a09cf35839cd
Dean_HealthPlan_Prenatal-Precon-Carrier-Screen-9575.pdf,d22ec533aba9fc631a4d9506dc635047
Carelon_Amerigroup_BCBSAlabama_Choromosomal_Microarray.pdf,54a26461fb3eccca9c518d89abe5b22d
Dean_HealthPlan_Genetic-Testing-Hematologic-9595.pdf,8fbe4e8f6f331df5ecbe1f61ef8d449f
BCBS_Kansas_genetic-testing-predisposition-inherited-hypertrophic-cardiomyopathy.pdf,aaad0c2ce68b51bded41e79af0b94759
Humana_Genetic Testing for Carrier Screening - Commercial.pdf,805b7a55adf248664cf83835df4d00f0
Amerihealth_Caritas_NH_ccp1466-molecular-analysis-targeted-tx-hepatobiliary-cancer.pdf,b620b776c42f7e446fa377b2d79b42c0
Ameriheath_Caritas_PA_ccp1235-genetic-testing-hereditary-cancer-susceptibility.pdf,565053f7e831223a0b2fb3317ad1df8c
Commonwealthcare_Maternal-Cell-Free-Fetal-DNA-Testing_MNG-110_11.21.24.pdf,9f70df02a8d93a2ed953f4a7b56700e2
Cigna_MOL.TS_.324.A_CHARGE_CHARGE_Syndrome_Genetic_Testing_eff01.01.2025_pub09.11.2024_0.pdf,721ac3e250433f7b08c2ad9ce656a1b5
Blue Cross Idaho_02.04.102_03-27-25.pdf,2e2c6aa9791bfb050e79031c83c1bda0
BCBS_HW_GTM Molecular Analysis for Gliomas AHS–M2139 2025-0301.pdf,59aed92fcb946f57c5b7b95d726517ed
BCBS_NE_V17.pdf,bf7f452b1fa5193852f92564707be9fe
Asuris_Northwest_Health_Measurable Residual Disease.pdf,1299a4be3a405aff5e49ea63cf188a6a
oxford_chromosome-microarray-testing-ohp.pdf,7b1657415ed17ceb4931b20efd3133c3
Cigna_MOL.TS_.410.A_Cardiomyopathy_and_Arrhythmia_eff01.01.2025_pub09.11.2024_0.pdf,093fe0a85b7fc879daeacc5c158af9f5
Cigna_MOL.TS_.288.A_Limb_Girdle_Muscular_Dystrophy_eff01.01.2025_pub09.10.2024_1.pdf,ae77c0c8dfa46d7c510335168080063e
RegenceBCBS.pdf,b0cef980ba18ec8928b1e60a6f61a681
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Eye-Disorders.pdf,220cae6afca876e84008920885dd867c
Cigna_MOL.TS_.130.A_Ataxia-Telangiectasia_eff01.01.2025_pub09.10.2024_1.pdf,e86aba32affb43119487cdff01e49f30
BCBS_HW_GTM Genetic Testing for Ophthalmologic Conditions AHS-M2083 2025-0201.pdf,ca44dd2c52ba1b58abb0bd56e3b38ae5
"AnthemBCBS_LAB.00033 Protein Biomarkers for the Screening, Detection and Management of Prostate Cancer.pdf",ecd28d73380c64a9fd1cbf4d62101577
Humana_Genetic Testing for Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Syndrome - Commercial.pdf,03fa94b35c116ec9aa40fd84514c9aba
BCBS_Illinois_RX501.133_2024-09-15.pdf,c763a24c9728b053adb6c54d1853bc16
Healthfirst_Diabetes-Mellitus-Testing.pdf,c6900ecd2a54f0505a0755a00f294589
HealthParners_lung disorders.pdf,927d68909c2ead145c46e3471dc9959c
SelectHealth.pdf,16be8d1e0e075042bcc92f48771c43e7
Blue Cross Idaho_02.04.106_02-27-25.pdf,a0c6f8020bdb9975ab29a9fdba3349e5
Blue Cross Idaho_02.04.044_03-27-25.pdf,a20ba20da1a3bd22a61bf4850a7e2aea
BCBS_FEP_204109 Genetic Testing for Epilepsy.pdf,ce1dc1242bd9704563e93b031e97e9a1
Cigna_MOL.TS_.168.A_Familial_Adenomatous_Polyposis_Testing_eff01.01.2025_09.10.2024_1.pdf,d13a9e20a6d1fbd46d0f61c11843cb88
BCBS_HW_GTM Genetic Testing for CHARGE Syndrome AHS–M2070 2023-0601_v2.pdf,92f5156e6065cdd85a1105dae4fc229d
Blue Cross Idaho_02.04.122_08-29-24.pdf,a8be64bad5b8b7f43099aeb29e00cdf8
Blue Cross Idaho_02.04.101_07-25-24.pdf,c4b16ce18e866fad9f0dca7ad572983d
BCBS_NE_V60.pdf,24b1a6cc691e9401926f3e184a098e07
Humana_Genetic Testing for Ehlers-Danlos Syndrome - Commercial.pdf,c077e53146bf2db04dd091a666b51877
BCBS_NE_V59.pdf,addee5221e3ef1d0f170dd8999a055ad
BCBS_Kansas_germline-genetic-testing-hereditary-breastovarian-cancer-syndrome-and-other-high.pdf,7e53651eeef0e34c6cf3b1d533add3fc
"Sentara_Genetic Testing-Cancer Prevention, Diagnosis and Treatment Medicaid - Medical 34A.pdf",5fd237ea155bdc0706dc420eb4ffa115
BCBS_Kansas_somatic-biomarker-testing-including-liquid-biopsy-targeted-treatment-metastatic.pdf,db97f43f30c7b51461b7540cfec4f246
Humana_Genetic and Biomarker Testing for Neurodegenerative Disease - Medicare Advantage.pdf,dc88467af0d12fe098784b905d77f869
IUHP_Molecular.Genetic-Testing.pdf,3d2791a8f15587c30732986c59a680b2
Cigna_MOL.CU_.109.A_Genetic_Testing_for_Cancer_Susceptibility_and_Hereditary_Cancer_Syndromes_eff01.01.2025_09.12.2024_0.pdf,9c8d74bb868ad55894a164f9152769a3
Blue Cross Idaho_02.04.126_08-29-24.pdf,3422633cd2716e4da530ea292822dc4c
Asuris_Northwest_Health_Noninvasive Prenatal Testing to Determine Fetal Aneuploidies- Microdeletions- Single-Gene Disorders- and Twin Zygosity.pdf,d44c0028786437407f1662a744b7b266
Blue Cross Idaho_02.04.114_02-27-25.pdf,c533d2b95c6dff40b028a848167ffc2e
BCBS_Kansas_gene-expression-profile-testing-and-circulating-tumor-dna-testing-predicting.pdf,a6338ab6c7430d040d122104187a00ce
Sentara_Genetic Testing-Cardioneurovascular and Developmental Diagnosis Medicaid - Medical 34C.pdf,675bf7aa3b90c21ff4638ca15c074138
BCBS_MA_677 Multibiomarker Disease Activity Blood Test for Rheumatoid Arthritis prn.pdf,a71fa8fd973195b6c759ce1204461a54
BCBS_FEP_20468 Laboratory and Genetic Testing.pdf,b46d8d2938ca941bde65407773e22f24
BCBS_Kansas_germline-and-somatic-biomarker-testing-including-liquid-biopsy-targeted-treatment.pdf,7c2f994b3a17e0a8af6e0766602dae8c
BCBS_Illinois_RX501.142_2024-09-15.pdf,de624600e7aa3966aa41cf65864dabb9
BCBS_MN_VI-09-015.pdf,36e2e69089f510fe22d11d031749ca6f
Cigna_MOL.TS_.301.A_ANF1_Neurofibromatosis_Type_1_Genetic_Testing_eff01.01.2025_pub09.10.2024_1.pdf,fcf74058cb7edfb6104673761ca1e438
"Sentara_Genetic Testing-Cancer Prevention, Diagnosis and Treatment Medicare - Medical 34A.pdf",9caa01c89a388b9f30c395f450a1643f
Asuris_Northwest_Health_BRAF Genetic Testing To Select Melanoma or Glioma Patients for Targeted Therapy.pdf,b519589b79f5103a175668e23a00c4d6
V2.2023 Concert Genetics Genetic Testing- Aortopathies & Connective Tissue Disorders.pdf,081bf0357a6b0a4d8e2680c8ff6fa680
Medica_Genetic-Testing-for-Exome-and-Genome-Sequencing-for-the-Diagnosis-of-Genetic-Disorders.pdf,23dda6ffd84c39daf8eea422d17773de
BCBS_AZ_gene-therapy-for-duchenne-muscular-dystrophy.pdf,71ec0f0ac4eb5f63420265315c2cde2f
Blue Shield of California_Blue Shield of California Promise Health Plan_Genetic-Test-Hematologic-Conditions-Non-Cancerous.pdf,67e105fb5fc8f30379160937fa4de0c3
BCBS_FEP_204139 Genetic Testing for Heterozygous.pdf,5276acf20bf3748569bd979cef98795b
Healthfirst_Alpha-1 Antitrypsin.pdf,16bf81eda0f1819b40bf0cca1d503e73
Medica_Genetic-Testing-General-Approach-to-Genetic-Testing.pdf,7ddf64cafabdebaf31e06426f8a73e07
BCBS_AZ_gene-therapy-for-hemophilia-b-beqvez-fidanacogene-elaparvovec-dzkt-hemgenix-etranacogene-dezaparvovec-drlb.pdf,a162a0b2cc11ef29ccb7a88647e91793
South Dakota Medicaid_Laboratory_and_Pathology_Services.pdf,ef9275753ab0c56bd64b15ad500426ad
Dean_HealthPlan_Onc-Molecular-Analys-Tumors-Malignancy-9608.pdf,1d80045942796d1b99693e8b71a22558
Oxford_fda-cleared-approved-companion-diagnostic-testing-ohp.pdf,09bd8172e045500e8e85d04881c31cac
BCBS_HW_GTM Genetic Testing for Neurodegenerative Disorders AHS–M2167 2025-0201.pdf,f4530e783d52c324e273d8ffb1c496af
BCBS_Illinois_RX501.084_2024-09-15.pdf,0c8f11d0c694089946c10b6677380ca8
Blue Shield of California_Blue Shield of California Promise Health Plan_Oncology-Cytogenetic-Testing.pdf,bcd1c06f39e40328fd84f7ccc25d0caa
BCBS_AZ_gene-therapy-for-dystrophic-epidermolysis-bullosa.pdf,5efa2c3a3481f85686db191e6e78508c
Amerihealth_Caritas_NH_ccp1282-genetic-testing-duchenne-muscular-dystrophy.pdf,f18009e53052aff63d2a8a16b245ed9d
BCBS_HW_GTM Genetic Testing For Germline Mutations Of the RET Proto-Oncogene AHS-M2078 2023-0601_v2.pdf,2b8cbeb47a8d90ee31634b2f8b9463c3
AnthemBCBS_MED.00144 Gene Therapy for Duchenne Muscular Dystrophy.pdf,298ce374bdcd969a6f089a95207c357b
